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In humans and other higher eukaryotes the observation of multiple splice 
isoforms for a given gene is common. However it is not clear whether all of these 
alternatively spliced isoforms are a product of true alternative splicing or some 
are due to DNA sequence variations in human populations. Genetic variations 
that affect splicing have been shown to cause variation in splicing patterns and 
potentially are an important source of phenotypic variability among humans. 
Furthermore, variation in disease susceptibility and manifestation between 
individuals is often associated with genetic polymorphisms that determine the 
way in which genes are spliced. Hence, identification of genetic polymorphisms 
that might affect the way in which pre-mRNAs are spliced is an area of great 
interest. 
Method 
We used the human genome and SNP annotations from the Ensembl and 
dbSNP databases, to study the prevalence of SNPs close to exon-intron 
junctions of human genes. We focused on SNPs located at exon-intron junctions 
because cis-acting motifs around the borders of exons and introns are known to 
be important for pre-mRNA splicing. In addition, we compared the distribution of 
SNPs at exon-intron junctions of alternatively spliced exons (ASEs) and those 
located in exon-intron junctions of constitutively spliced exons (CSEs). We further 
use SNP allele frequency information from HapMap to look at how natural 
selection has shaped the distribution of SNPs in the exon-intron junctions. 
Results 
We used 4 736 096 genotyped SNPs from dbSNP of which 47 036 SNPs map to 
5' and 3' exon-intron junctions. These SNPs are mostly located in the non-coding 
intronic regions of the junction. We observed that exonic positions are 
significantly less diverse with a higher proportion of rare (frequency $ 0.1) 
derived alleles than intronic positions. We also showed that ASE junctions have 











comparative genomic study which suggests increased conservation of 
sequences flanking ASEs relative to CSEs. 
SNP frequency data from three human populations (European, Asian and 
African) showed lower frequency of non-synonymous SNPs located near exon 
boundaries relative to synonymous SNPs, non-coding SNPs and SNPs found in 
the 5' and 3' splice junctions, as expected, reflecting purifying selection against 
mutations disrupting amino acid sequence of a protein. We also observed an 
increased frequency of synonymous SNPs close to boundaries of CSEs relative 
to corresponding regions of ASEs, suggesting stronger purifying selection acting 
on intron-exon junctions of ASEs. 
Conclusion 
The frequency in which SNPs occur and the SNP frequency spectra, provide 
information about the functional constraints acting on genomic sequences. As we 
expect, therefore, sequences close to the exon boundaries and splice sites had a 
low rate of occurrence of SNPs. We observed differences in the prevalence and 
frequency spectra of SNPs close to intron-exon boundaries of CSEs and ASEs 
and suggest that these differences reflect differences in the selection pressures 
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DNA Deoxyribonucleic acid 
RNA Ribonucleic acid 
SNPs Single nucleotide polymorphisms 
srSNP splicing regulatory SNP 
ASEs Alternatively spliced exons 
CSEs Constitutively spliced exons 
SJ Splice Junction 
ESE Exonic splicing enhancer 
ISE Intronic splicing enhancer 
ESS Exonic splicing silencers 
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1.1 Theoretical and Conceptual Framework 
The 3 billion base pair (bp) that make up the human genome encode between 20 
000 and 25 000 protein coding genes (Lander et a/., 2001; Venter et a/., 2001). The 
protein complement expressed from these genes is, to a large extent, responsible 
for the biochemical processes carried out by human cells. The different human cells 
produce many and diverse transcripts which are translated to proteins that carry out 
the complex biochemical processes responsible for human physiology. Hence, 
human biological complexity is carried by fewer genes than expected, with 
expressed sequences far exceeding the number of genes encoding them (Hillier et 
a/., 1996; Velculescu et a/., 1999). 
In theory, there are many ways in which a relatively small number of genes could be 
manipulated so as to generate diversity of gene expression products. However, 
alternative pre-mRNA splicing of genes has been the most often cited mechanism 
adopted by eukaryotes to increase protein diversity from relative small number of 
genes (Gravely, 2001; Kan et a/., 2001). The mechanism allows generation of 
differently spliced transcript from a single gene through alternative use of splice 
sites. When a gene is alternatively spliced, it produces different transcript patterns; 
consequently, different protein isoforms from a single gene are produced. 
Genome-wide estimates of alternatively spliced genes in human indicate that the 
mechanism is more prevalent than previously thought; with recent studies estimating 
more than 60% of human genes as alternatively spliced (Modrek et a/., 2001; 











discovered, a genome-wide understanding of the regulation of the process is still to 
be achieved. 
1.2 The research Problem 
Besides alternative splicing, natural genetic variations between individuals also 
contribute to transcript diversity (Buckland, 2004; Stranger et a/., 2005). This allelic 
variation in the human population contributes to human protein diversity. The most 
abundant genetic variations in the human genome are single nucleotide 
polymorphisms or SNPs (Kruglyak & Nickerson, 2001). SNPs are a useful resource 
in association studies, gene mapping, pharmacogenomics and evolutionary biology. 
Hence, several studies are aimed at associating SNPs with varied drug treatment 
response (Legro et a/., 2008), disease susceptibility (Prokunina et a/., 2002; Miao et 
a/., 2003) and other phenotypic variation among human populations (Oleksiak et aI, 
2002; Bercovich et a/., 2006). 
The presence of SNPs within splicing regulatory regions have been associated with 
occurrence of different transcript isoforms of the same gene (Nembaware et a/., 
2004; Hull et a/., 2007; Kwan et a/., 2007). Several examples of SNPs have been 
associated with subtle or severe phenotypic changes in human genes (Stranger et 
a/., 2005; Kwan et a/., 2008) and some are implicated in heritable diseases 
(Krawczak et a/., 1992; Kozyrev et a/., 2008). Therefore, genome-wide discovery of 
SNPs that affect splicing has the capacity to accelerate the association of genetic 
variants to transcript isoform variation between individuals. It has already been 
estimated that 21 % of alternatively spliced genes are affected by polymorphisms 
that alter splicing (Nembaware et a/., 2004), but no detailed investigation has 












1.3 Potential of Bioinformatics Tools 
Most prediction of alternative splice events relies on evidence of expression of 
alternative combinations of exons from a single gene. The availability of the human 
genome sequence and gene expression technologies (i.e. EST, cDNA, and 
microarray) enable bioinformatics analysis of alternatively spliced genes. As a result, 
to date there are numerous databases of alternatively spliced genes which have 
been created (See Table 2.2), making it possible to obtain a catalogue of 
alternatively spliced genes, their genomic sequences and different mRNA isoforms. 
A subsequent analysis of the human genome project was the identification of 
genetic variation within and between human populations (Sherry et al., 2001). The 
millions of SNPs genotyped and deposited in databases (See Table 2.3) provide us 
with the opportunity to explore genetic variants that are located within splicing 
regulatory sequences. These are likely to affect pre-mRNA splicing and can be 
associated with transcript variants which contribute to phenotype diversity among 
humans. Hence, a genome-wide survey of splicing regulatory SNPs (srSNPs) will 
support detection and estimation of the prevalence of allele-specific splicing in the 
human genome. 
Presently, it is not clear whether most of the transcript isoforms found in databases 
of alternatively spliced genes are true alternative splicing events (same allele can 
result in different splice patterns within an individual) or some arise from SNPs that 
affect the way in which mRNAs are spliced. However, there has been reliable 
identification of genetic variations (i.e. SNPs) from human expressed sequences 
(Picoult-Newberg et al., 1999; Kenneth et al., 1999; Cargill et al., 1999) which 
support identification of inherited genetic variation associated with transcript 
variation. Therefore, the available data sets of alternatively spliced genes and SNPs 
permit studies aimed at determining the extent of transcript variants which are the 












1.4 General Objectives 
It is important to identify and estimate the occurrence of SNPs close to exon-intron 
boundaries because SNPs in this genomic region are likely to alter transcript splice 
pattern, thus contributing to phenotypic diversity at a molecular level. This allele-
specific splicing may be mistaken for alternative splicing,subsequently 
overestimating the prevalence of alternatively spliced genes in the human genome. 
Hence, before we can attribute multiple transcript variants of a gene to alternative 
splicing, it is necessary to distinguish between transcript variants which are the 
result of true alternative splicing, possibly serving to increase the coding capacity of 
a gene, and transcript variants resulting from genetic polymorph isms, which may be 
responsible for some phenotypic variation between individuals. It is against this 
background that the current investigation aims to establish the prevalence and allele 
frequencies of SNPs at exon-intron junction regions of human genes. 
1.5 Specific Objectives 
In response to the need to identify and generate a catalog of genetic polymorph isms 
that might affect mRNA splicing, this study looked at the distribution of SNPs in the 
exon-intron junctions of human genes. We focused on SNPs located at exon-intron 
junction regions because nucleotide sequences which form the borders of introns 
and exons contain sequence motifs essential for pre-mRNA splicing (Mount, 1982; 
Shapiro & Senapathy, 1987; Jackson, 1991). 
Exons and introns affected by alternative splicing have distinct features compared to 
constitutively spliced exons (Sorek & Ast, 2003). Hence, we further compare the 
distribution of SNPs at exon-intron junctions of alternatively spliced exons (ASEs) 
and constitutively spliced exons (CSEs). This knowledge will facilitate understanding 












Although many of the SNPs occurring at the exon-intron junctions could be neutral 
mutations in which different genotypes have the same fitness, a fraction of 
polymorphisms in this region are expected to affect mRNA splicing. SNPs located at 
pre-mRNA splicing regulatory motifs may affect the way in which genes are spliced, 
resulting in different splice patterns which may play an important role in phenotypic 
diversity and/or genetic disorders between individuals (Faustino & Cooper, 2003; 
Nissim-Rafinia & Kerem, 2002). For example, SNPs disrupting the splice sites and 
exonic splicing enhancers (ESEs) might be associated with deleterious transcripts 
and are expected to be eliminated through purifying selection (Eskesen et al., 2004; 
Parmely et al., 2006). 
It is beyond the scope of our analysis to directly study the transcript expression 
pattern associated with each SNP located at exon-intron junction; however, we 
examined the effect of polymorph isms on function indirectly by analyzing the 
inferred effects of natural selection on the polymorphic sites at the exon-intron 
junction splicing regulatory sites. The aim is to understand the role of natural 
selection in shaping the distribution of SNPs at the exon-intron junction. Hence, we 
used SNP allele frequency information to investigate the influence of natural 
selection on distribution of SNPs at the exon-intron junctions and compare this 
between alternatively and constitutively spliced exons. 
1.6 Thesis outline 
The thesis is composed of six chapters and the main issues discussed in each of 
the chapters are indicated as follows: 
Chapter Two provides an overview of the biology of pre-mRNA splicing and 
alternative splicing. The current understanding and genomic sequences that are 
involved in regulation of splicing are also outlined. We also looked into 











splicing. Finally we considered human genetic variations and the influence of SNPs 
on the way in which genes are spliced. 
Chapter Three describes the methods used to generate the human exon and SNP 
datasets. The datasets were derived from publicly available genomic information in 
biological databases. A genome-wide analysis of human SNPs and exons was 
undertaken. We identified exon-intron junctions and characterized the exons as 
constitutively and alternatively spliced. 
Chapter Four focuses on the analysis of the prevalence of SNPs found at exon-
intron regions. SNPs found at exon-intron junctions might affect efficiency of 
splicing. The chapter also describes a comparison of the prevalence of SNPs at 
exon-intron junctions of CSEs and ASEs. 
In Chapter Five, we assess how natural selection has influenced the distribution of 
SNP allele frequencies at exon-intron junctions. Using population specific SNP 
frequency information we carried out a qualitative assessment of natural selection 
by comparing patterns of derived allele frequencies between SNPs located at non-
synonymous sites, synonymous sites, non-coding regions and SNPs located in 
exon-intron junctions. 
Discussions of the main trends, patterns, and connections that may emerge from the 
results are presented in each chapter. The thesis is concluded by presenting, in 
Chapter Six, a summary of important points, main conclusions and possible 
implications of our research. Closely tied to general discussion is the discussion of 














Human protein coding genes consist of segments of coding sequences interrupted 
by segments of non-coding sequences. The non-coding sequences, the introns, get 
transcribed into precursors of messenger RNAs (pre-mRNAs) but they are not 
translated into proteins. The coding segments, the exons, are actually the ones that 
are joined together, forming the mature mRNA sequence that gets translated into 
the amino acid sequence of a protein molecule. An initial focus of this review is a 
description on how introns are removed from expressed genes and exons are joined 
together during a pre-mRNA processing reaction referred as pre-mRNA splicing. 
Exons from the same gene can be arranged and joined differently during pre- mRNA 
splicing to produce different mRNA isoforms through alternative pre-mRNA splicing 
(Smith & Valcarcel, 2000; Smith & Roberts, 2002). Alternative splicing is a 
mechanism that can increase the protein-coding capacity of eukaryotic genes 
(Gravely, 2001; Black, 2000; Kan et al., 2001). However, some of the diversity of 
human gene products might be a result of genetic variation, which may account for 
some of the phenotypic variation found in the human population. Natural genetic 
variation has been shown to control differential expression of gene transcript isoform 
through their affects on pre-mRNA splicing (Nembaware et al., 2004; Hull et al., 
2007; Kwan et al., 2007). Hence, apart from a discussion on phenotypic variation 
within the individual due to alternative splicing, we will also discuss how genetic 












2.2 pre-mRNA Splicing 
Splicing is a pre-mRNA modification process that occurs during gene transcription 
(Gilbert, 1978). The process involves removal of non-coding introns from a gene and 
joining adjacent exons to form mature RNA (Figure 2.1). The resulting mature RNA 
(mRNA) contains coding sequences required for translation of a gene to protein. In 
general, introns tend to be much longer than exons with an average eukaryotic exon 
less than 200bp long (Hawkin, 1988; Berget, 1995). Accurate removal of the longer 
introns and constitutive joining of adjacent exons is accomplished through precise 
identification of the splice sites found at the intron termini. 
pre-mRNA 
-.- -----: ... 
mRNA 
Figure 2.1: Schematic representation of a eukaryotic gene open reading frame (ORF). Exons are 
shown as boxes and introns as straight lines connecting the exons. The angled doted lines show 
splice sites where introns are removed from pre-mRNA to produce mRNA. 
2.2.1 Mechanisms of pre-mRNA Splicing 
2.2.1.1 Trans-acting splicing regulatory proteins 
The splicing reaction is regulated by the spliceosome, which is a large multi-
component protein (Burge et a/., 1999; Graveley, 2000). The spliceosome consists 
of five small nuclear ribonucleoprotein particles (snRNPs). The U1, U2, U4/U6 and 
U5 snRNP molecules are associated with a large number of proteins, including SR 











the pre-mRNA and serves as an enzyme which catalyzes the pre-mRNA splicing 
reaction (Ladd & Cooper, 2002). 
SR proteins are splicing factors that are also important in pre-mRNA splicing. These 
trans-regulatory proteins contain an RNA recognition motif (RRM) which binds to 
distinct pre-mRNA sequences and recruits a number of other splicing factors, 
including the components of the spliceosome (Wu & Maniatis, 1993; Kohtz et a/., 
1994; Zuo & Maniatis, 1996). Thus, they promote the assembly of the different 
inactive components of the spliceosome into a functional and active enzyme (Wu & 
Maniatis, 1993; Graverly & Maniatis, 1998; Graveley, 2000). It is the snRNP 
component of the spliceosome, not the SR proteins, which catalyzes the splicing 
reaction. The SR proteins only recruit the different spliceosome components and 
assist in activating the enzyme and recognition of splice sites (Norton, 2004; 
Graveley, 2000). 
2.2.1.2 Cis-acting splicing regulatory proteins 
Although the splicing machinery, the spliceosome, has the role of finding short exon 
sequences among longer introns, it accomplishes this with high accuracy. Efficient 
constitutive splicing is achieved through accurate identification of the 5' splice site 
(at the 5' end of the intron) and 3' splice site (at the 3' end of the intron). It is the 
recognition of special sequence features found in the junction between the introns 
and exons by the spliceosome that drives the process. The 5' splice (donor) site and 
the 3' splice (acceptor) site sequences are key genomic elements required for 
removal of introns (Mount, 1982; Shapiro & Senapathy, 1987). 
The 5' splice site is located at the junction between the upstream exon and the 5' 
end of an intron whereas the 3' splice site is located at the junction between the 3' 
end of the intron and the downstream exon (Figure 2.2). Almost all introns are 











end. In addition, the 3' end of the intron is defined by the branch point located 
approximately 20 bases from the 3' intron boundary and the polypyrimidine tract 
(Pyr-rich) near the 3' splice site. 
, .,-
"" '" ,0>: "" 
Figure 2.2 ; Cis-.c!ing splicing rcgulalor~ sequences These are kx.tcd at the junction between an 
exon and an intron , termed the cxon-intron jl1f1CtiDll. The Invariant basc5 the GU and AG found at 
the 5' ",d 3' inlron ood po"itions are highlighted in blue. A pyrm <1ine-rich region (Iighl blue 
brlgcaund) nco' the 3' end of the intron " composec of continuous sequence of approximately 15 
u, ldines. The branch-pc",,! .denosn e is usually found 20 - 50 bp from the 3' end of the intron. The 
frequency 01 the nucleolice is ind<;a!cd be low ils position. (Source' Lodish ot al., 2(03) 
The cis-actil"lg splicing regulatory sequences are often conserved between 
vertebrates (Mount, 1982: Burset et aI., 2000) and this is an indication of their 
functional significance However, these genomic features do not provide sufficient 
information for recognition of exons and the splice sites located in the exon-intron 
junctions. These sequences are short arxl highly degenerate. There are many 
sequences in the human genome that resemble them, making it difficult to 
distinguish between real and cryptic splice sites Besides, mutations in the 
conserved sequences may occur and this can lead to activation of cryptic splice 
sites (Treisman et al .. 1983; Wieringa el al .. 1983). Hence, additional pre-mRNA 
sequence features are necessary to determine recognition of the correct splice site 
and ensure efficient pre-mRNA splicing. 
In addition to the crucial splice sites, human pre-mRNA sequences contain less 
conserved sequence features that acts as exonic splicing enhancers (ESE). intronic 
splicing enhancers (ISE), exonic splicing silencers (ESS) and intronic splicing 
silencers (ISS) (Baralle & Baralle, 2005). These sequences are found close to the 
splice sites, The spliceosome makes use of these diverse exonic and intronic 











and utilize exonic and intronic splicing silencer sequences to obstruct their 
recognition (Cartegni, et a/., 2002). ESEs in particular are common in most exons. 
Several studies have identified a range of ESE motifs and concluded that these 
sequences are short (6-8nt), have high purine content, and sometimes overlap (Liu 
et a/., 1998; Cartegni, et a/., 2002; Fairbrother et a/., 2002). Besides supporting the 
recognition of weak splice sites, ESE sequences are binding sites for SR proteins 
and are highly specific (Graveley, 2000; Blencowe, 2000). 
ESS and ISS sequences are less well defined than splicing enhancers. The most 
described silencers are intronic elements but exonic splicing silencers have also 
been found (Amendt et a/., 1995; Kan & Green, 1999). Obstruction of splice sites by 
silencers involves binding of heterogeneous ribonucleoprotein particles (hnRNPs) to 
the silencer sequences (Choi et a/., 1986; Lopez, 1998), which then block the 
activity of SR proteins (Caceres & Krainer, 1997; Smith & Valcarcel, 2000). Binding 
of hnRNPs to ESS and/or ISS result in inaccessibility of enhancers and splice sites 
to SR proteins (Del GaUo-Konczak et a/., 1999; Cartegni et a/., 2002). 
2.2.1.3 Biochemistry of pre-mRNA splicing 
After the recognition of splice sites and the activation of the spliceosome, the pre-
mRNA splicing reaction takes place in two trans-esterification reactions (Ruskin et 
a/., 1984; Guthrie, 1989; Lodish et a/., 2003). Firstly, the intron is cleaved at the 5' 
splice site, producing two intermediates product: the upstream exon and an RNA 
structure composed of the intron and downstream exon called an intron lariat. In the 
second reaction, the intron is cleaved at the 3' splice site and the two adjacent 
exons are ligated generating an mRNA, subsequently eliminating the intact intron. In 
each trans-esterification reaction, one phosphate-ester bond is exchanged for 
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2.3 Alternative pre-mRNA splicing 
2.3.1 Alternative splicing in the human genome 
During pre-mRNA splicing different choices of splice site pairs can be used allowing 
exons that are arranged and joined in different spliced mRNA patterns, a process 
referred as alternative pre-mRNA splicing. Figure 2.4 show how introns can be 
removed and differently spliced exon patterns are joined together through 
recognition of different splice sites by the spliceosome. During alternative pre-mRNA 
splicing, an exon may be skipped, shortened, extended or an intron may be retained 
in the final mRNA product. Intron retention involves failure to remove an intron 
during pre-mRNA splicing. However, for an intron to be retained it must be properly 
encoding for amino acids that can be incorporated into the translated protein. Intron 
retention is one of the rare forms of alternative splice patterns (Ladd & Cooper, 
2002) whereas exon skipping is very common in humans (Modrek & Lee, 2003; Yeo 
et al., 2004). 
Although constitutively spliced exons outnumber alternatively spliced exons (Clark & 
Thanaraj, 2002; Sorek et al., 2006), computational analysis of available transcript 
sequences infer that more than half of human protein coding genes have one or 
more exons that are alternatively spliced (Modrek et al., 2001; Johnson et al., 2003). 
When a gene is alternatively spliced, it can produce different mRNA sequence 
patterns or isoforms. Accordingly, each gene can produce between two and dozens 
of transcript patterns depending on the number of alternatively spliced exons. As a 
consequence this allows phenotypic diversity at a molecular level which can further 
produce several distinct proteins from a single gene (Lopez, 1998; Smith & 
Valcarcel, 2000; Smith & Roberts, 2002; Black, 2003). For example, alternative 
splicing generates multiple SMRT gene transcripts encoding variable protein 
isoforms which differ in their ability to interact with nuclear receptors (Malartre et al., 











by mammalian genomes to increase their protein complexity from relative small 
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Besides protein diversity, alternative splicing is also responsible for regulation of 
gene expression (Smith et al., 1989, Nissim-Rafina & Kerem, 2002). For example, 
alternative splicing can be used to modify or remove a functional domain from a 
protein. In such cases, alternative splicing operates to up or down regulate gene 
expression (Smith et al., 1989; Lopez, 1998; Woodley & Valcarcel, 2002). In 
addition, RNA stability and translation efficiency can be controlled by differential use 
of alternative untranslated regions (Hughes, 2006). Lastly, alternative splicing can 
regulate expression of mRNA isoforms that result in premature termination codons, 
by linking with nonsense-mediated mRNA decay (NMD) (Lewis et aI., 2003; Lejeune 
& Maquat, 2005). 
2.3.2 Regulation of alternative pre-mRNA spliCing 
There is still a lot to be learned about the trans- acting regulatory factors that control 
production of transcript variation based on alternative splice patterns, and about the 
distribution of cis-regulatory elements through which they act. Nevertheless, we 
know that the general pre-mRNA sequence features and splicing factors involved in 
the regulation of constitutively spliced exons (CSEs) are also implicated in regulation 
of alternatively spliced exon (ASEs). Regulation of alternative exon patterns occurs 
during splice site selection. 
The decision of whether to include an exon and how it is included in the mRNA 
depends on the strength of the splice site elements around it (cis-acting) combined 
with availability and interaction of splicing-associated proteins (trans-acting). 
Splicing-associated proteins are differentially expressed in response to different 
cellular environment, suggesting a fundamental role of expression levels of these 
proteins in the regulation of alternative splicing (Zahler et aI., 1993). Hence, some 
studies are aimed at clarifying the molecular mechanism that control changes in 











Most of alternative splicing events that are analyzed from human genes show that 
the process is controlled by cellular conditions (Maniatis, 1991; Xu et al., 2002; 
Black, 2003); that means, pre-mRNA from the same gene produce different mRNA 
isoforms in different cell types, developmental stage (Lopez, 1998; Xu et al., 2002; 
Black 2003) or in response to different external stimuli (Stamm, 2002). For example, 
alternative 3'splice site usage associated with differential use of polyadenylation 
sites in the calcitonin gene related peptide (CGRP) generates two distinct mRNA 
isoforms. One isoform is expressed in the thyroid gland and encodes calcium 
homeostatic hormone whereas the other isoform is expressed in the nervous system 
and encodes vasodilator neuropeptide (Smith & Valcarcel, 2000). 
Cell or tissue specific alternative splicing regulation is due to existence of trans-
acting splicing factors which bind specifically to exonic or intronic enhancer and 
silencer elements in cell or tissue regulated manner (Norton, 1994; Graveley, 2000). 
This is clearly demonstrated by the different members of SR family of proteins that 
specifically bind with particular ESE sequences in the pre-mRNA. (Wu & Maniatis, 
1993; Tacke et al., 1997). Which transcript isoforms are produced in a cell will 
depend on the availability of both the specific binding sites and the corresponding 
SR protein. In their review, Faustino and Cooper (2003) concluded that cell or tissue 
specific transcript isoforms emerge primarily from two features. Firstly, the 
repression of splice site choice in the unsuitable cell type is combined with activation 
of splice site in appropriate cell type. Secondly, the relative expression levels of 
trans-acting splicing factors in different tissues controls which cis- acting elements to 
be used during splicing, which in turn enhance or inhibit the recognition of the splice 
sites by the spliceosome. 
Comparative analysis of alternative splicing events in multiple organisms revealed 
that most conserved alternatively spliced exons have weak splice sites, are 
comparatively short, and are likely to be multiple of 3nt in length (Sorek et al., 2004; 
Yeo et al., 2005; Xing & Lee, 2005). In addition, studies have shown that regions 











conservation compared to those of orthologous CSEs (Sorek & Ast, 2003; Yeo et 
al., 2005) but no function could be assigned. Species (i.e. human or mouse) specific 
ASEs did not show greater sequence conservation than CSEs (Zheng et al., 2005). 
Alternatively spliced exon length allow flexibility in the way in which the exons are 
arrangement in the mRNA (Xing and Lee, 2005). Consequently, ASEs are arranged 
in such a way that their inclusion or exclusion does not disrupt or truncate the 
protein reading frame. This allows inclusion or exclusion of specific functional 
domains in a protein while maintaining the general function of the gene from which 
the protein is encoded. Skipping or inclusion of exons occurs in such a way that 
there is expression of tissue specific isoforms with or without the functional domain. 
2.3.3 Alternative pre-mRNA splicing and human diseases 
Under normal conditions, alternative pre-mRNA splicing is highly regulated. 
However, abnormal splice site choices sometimes do occur, resulting in alternatively 
spliced patterns leading to human pathologies. The control of alternative pre-mRNA 
splicing can be deregulated and this may result from alteration within splicing 
regulatory factors (Baralle & Baralle, 2005). Table 2.1 shows a list of genes in which 
alterations in either cell signaling pathways, trans-acting or cis-acting splicing 
regulatory factors which results in aberrantly spliced mRNA isoforms that are 
involved in disease progression. 
Although we have explained pre-mRNA splicing as if it is biochemically separated 
from other pre-mRNA processing steps (i.e. capping and polyadenylation) that occur 
during gene transcription, in reality this processes is tightly coordinated and coupled 
with transcription (Maniatis & Reed, 2002). Therefore, any factors that affect gene 
transcription regulation are likely to also influence pre-RNA splicing regulation and 











Inappropriate cell signals or environmental stimuli can negatively affect regulation 
and expression of trans-acting splicing regulatory factors (Tarn, 2007). SR proteins 
expression levels are influenced by different cell transduction pathways and cell 
environments, consequently, these proteins are differentially phosphorylated in a 
way that directly influences their biochemical properties (Xiao & Manley, 1998; 
Prasad et al., 1999). Unsuitable phosphorylation status of SR proteins may 
subsequently affect their cellular localization, their interaction with other proteins, or 
binding affinity with ESEs. When SR protein expression is not properly regulated, it 
might affect splice site choice which might direct synthesis of abnormal transcript 
pattern. 
Modifications in spliceosome components are generally associated with serious 
disease phenotypes in humans. For example, modifications that disrupt the 
assembly or function of the spliceosomal snRNPs are responsible for Retinitis 
pigmentosa, and spinal muscular atrophy (Faustino & Cooper, 2003). Four 
components of the splicing machinery (U2AF35 , Sm protein 01, SF3b subunit 4, and 
U1CA) were identified as genes required for early vertebrate developments (Golling 
et al., 2000). All these four genes are implicated in developmental defects that are 
thought to result from mutations. 
Mutations occurring at cis-acting splicing regulatory regions, especially the 
conserved GT donor splice site or AG acceptor splice positions may create loss of 
function of the splice site or reduce binding specificity for splicing factors. Mutation 
occurring at splice site or those creating cryptic splice sites can lead to formation of 
inappropriate exon pattern (Skrygan et al., 2001) or abnormal intron inclusion in the 
mRNA. Aberrant mRNA can be unstable (Kinniburgh et aI, 1982) or translate to 
lethal proteins (Krawczak et al., 1992; Cartegni et al., 2002). In addition, a study of 
mutations associated with human inherited diseases observed that 15% of these 
point mutations are located at the intron-exon junctions and affect splicing 
(Krawczak et al., 1992; Cartegni et al., 2002; Hudson & Pastinen, 2004). As a 











cause exon skipping in BRCA 1 gene, which subsequently results in cancer (Liu et 
al., 2001). 
Several genetic disorders and many forms of cancer are caused by nonsense 
mutations which promote premature translation termination (Frischmeyer & Dietz, 
1999; Mendell & Dietz, 2001). Nonsense mutations produce shortened non-
functional proteins, supposedly targeted for NMD (Hentze & Kulozik, 1999; Lewis et 
al., 2003). There is evidence of connection between NMD and pre-mRNA alternative 
splicing (Lejeune & Maquat, 2005), suggesting that aberrantly spliced exons due to 
nonsense mutations are degraded from the cells. Possible consequences of an 
aberrant spliced transcript due to nonsense mutation can be serious in the absence 











Table 2.1: Genes in which a mutation results in aberrant alternative splicing patterns that are implicated in disease 
Gene Gene name Mechanism Disease Reference 
Symbol 
ADA Adenosine deaminase Cis - acting mutation Adenosine deaminase deficiency Ozsahin et al., (1997) 
ALG3 Asparagine-linked glycosylatior ESE activated upstream Congenital disorder Denecke et al., (2004) 
homolog cryptic ss 
APOA2 Apolipoprotein A-II 5'ss ApoA2 deficiency Deeb et al., (1990) 
BRCA1 Breast Cancer 1 Cis - acting mutation Breast Cancer Liu et al., (2001) 
CA21HB Steroid21-hydroxylaseB gene 3'ss Adrenal hyperplasia Higashi et al.,(1988) 
CFTR Cysticfibrosis transmembra 3'ss Cystic Fibrosis Delaney et al., (1993) 
conductance regulator 
COL1A2 collagen, type I, alpha 2 3'ss Osteogenesis imp. II Tromp & Prockop (1988) 
CYBB Cytochrome b-245, 5'ss disruption Chronic granulomatous Ishabashi et al., (2001) 
beta polypeptide 
DMPK Dystrophia myotonica- Trans - acting mutation Myotonic dystrophy Mankodi et al., (2000) 
protein kinase 
F9 Coagulation factor IX precursor 5'ss Haemophilia B Rees et al.,(1985) 
FBN1 Fibrin 1 Cis - acting mutation Marphan Syndrome Liu et al., (1997) 
GH-1 Growth hormone 1 Cis - acting mutation Growth hormone deficiency type II Moseley et al., (2002) 
HBA2 Hemoglobin, alpha 2 5'ss created ex thalassaemia Harteveld et al., (2004) 
HBB Hemoglobin, beta 3'ss Thalassaemia 13 Atweh et al.,(1985) 











Table 2.1 (continued) 
Gene Gene name Mechanism Disease 
Symbol 
MAPT Microtubule-associated protein Cis - acting mutation Frontotemporal dementia 
tau and Parkinsonism 
OAS1 2',5'-oligoadenylate synthetase 3'ss Susceptibility in viral infection 
PAH Phenylalanine hydroxylase ESE disrupted Phenylketonuria 
PDHA1 Pyruvate dehydrogenase ESE disrupted Leigh syndrome 
PKLR Pyruvate Kinase liver and 5'ss Pyruvate Kinase deficiency 
red blood celis 
PMM2 Phosphomanomutase ESE disruption Glycoprotein deficiency 








receptor type C 
phosphata Cis - acting mutation 
Retinoblastoma tumor suppressE 5'ss 
Survivor motor neuron 1 ESE disrupted 
Transforming growth factor, 5'ss 
beta receptor II 
Uroporphyrinogen decarboxylate 5'ss 
Multiple schlerosis 
Retinoblastoma tumor 




Lee et al.,(2001) 
Bonnevie-Nielsen et al., (2005) 
Chao et al.,(2000) 
De Meirleir et al. (1994) 
Kanno et al.,(1997) 
Vuillaumier-Barrot et al., (1999) 
Vithana et al.,(2001) 
Jacobsen et al., (2000) 
Dunn et al., (1989) 
Lorson et al.,(1999) 
Mizuguchi et al., (2004) 











2.3.4 Bioinformatics analysis of Alternative splicing 
Prior to high-throughput sequencing of genomes, few alternatively spliced genes 
were identified using molecular biology techniques. However, with the advent of 
Genome-wide sequencing it has been possible to identify and characterize novel 
alternative splice patterns using bioinformatics approaches. As a consequence, a 
growing number of alternatively spliced genes have been identified. Genome-wide 
analysis estimates that more than 60% of human genes are alternatively spliced 
(Modrek et al., 2001; Johnson et al., 2003). 
There are many computational methods used to detect alternatively spliced variants 
of a gene. These include prediction of alternatively spliced exons using comparative 
genomics (Modrek & Lee, 2003; Sorek & Ast, 2003; Sorek et al., 2004) and ab initio 
prediction (Phillips et al., 2004; Sorek et al., 2005). Nevertheless, the most 
commonly used methods to identify alternatively spliced genes utilizes expressed 
sequence Tags (Mironov et al., 1999; Modrek, et al., 2001; Xu et al., 2002) and 
microarray data (Hu et al., 2001; Shoemaker et al., 2001; Clark et al., 2002; 
Johnson, 2003; Kampa et al., 2004). 
2.3.4.1 cDNA and EST based approach 
Complementary DNA (cDNA) and Expressed sequence tags (ESTs) are expressed 
sequences which represent the expression profile of a gene. cDNA is a single 
stranded DNA that has been synthesized from the expressed mRNA molecule under 
specific physiological condition of a cell (Kimmel et al., 1987; Belyavsky et al., 1989; 
Huang, 2002), whereas, an EST is a fragment of expressed sequences generated 
by single-pass sequencing from either a 5' or 3' ends of a cDNA clone (Boguski et 
al., 1993; Boguski & Schuler, 1995). The production of ESTs requires the 
construction of a cDNA library that represents the transcriptome of the tissue or cell 











tissue or cell condition. An EST cluster is a collection of ESTs that provides 
information about the expression pattern of a gene under different physiological 
conditions and is constructed to identify structural features of genes, such as gene 
boundaries, exon-intron junctions and alternatively spliced variants (Mathe et al., 
2002). 
Alternatively spliced variants of genes are detected by computational methods that 
align ESTs or cDNA sequences to genomic sequences (Figure 2.5). The aim is to 
establish the structure of a gene on the genomic sequence, based on the transcript 
alignment. The genomic regions that match the transcribed sequences are exons 
and the alignment gaps between them are considered to be introns. During the 
alignment not only the degree of similarity of the sequences is taken into account, 
but also the intron-exon junction sequences are checked for the presence of splice 
signals (GT- AG, polypyrimidine tract, etc). In a widely cited survey, Modrek and 
colleagues reported alternative splicing events of a gene when two or more 
transcribed sequences overlap in the genomic sequence (Modrek, et al., 2001 ). 
The use of EST data is extremely helpful in identifying structural features of genes 
and alternative splicing; however, there are noted limitations to this approach 
(Mironov et al., 1999; Brett et al., 2000). Firstly, since ESTs are single-pass reads 
and their sequences are usually between 300-500 bases in length, the quality of the 
sequence is sometimes low and errors are common. Secondly, EST sequencing 
covers mostly terminal ends of the transcript; consequently internal exons of long 
transcripts are poorly represented. This makes it difficult to predict alternatively 
spliced patterns of internal exons using ESTs. Thirdly, it is not clear how many of the 
ESTs represent functional transcript or aberrant splicing, hence, further 
experimental validation of the functional impact of the alternatively spliced variants 
may be needed. Finally, although some cDNA libraries are normalized (Bonaldo et 
al., 1996), clones containing rare transcripts are likely to be poorly represented or 
completely absent from the cDNA library, as a result, rare alternatively spliced 
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2.3.4.2 Microarray based approach 
cDNA and oligonucleotide microarray technologies were initially developed for 
parallel analysis of expression profiles of many genes (Schena et a/., 1995). These 
methods are mostly used to detect the changes in gene expression profiles across 
tissues or different experimental conditions. Lately, there is a growing trend on using 
microarrays to identify alternative splicing (Shoemaker et a/., 2001; Clark et a/., 
2002; Johnson, 2003). It is possible to investigate whether a transcript isoform is 
enriched in some cell or tissue types using microarrays. 
The common approach to detect alternative splicing is to design oligonucleotide 
probes for exon-exon junctions. As Lee and Roy (2004) highlighted, it is important to 
have probes complementary to every exon-exon junction of a given gene since 
different transcript isoforms have distinct exon-exon junctions. Hybridization data 
from the junction probe of each transcript are then analysed and compared across 
tissue samples to detect distribution of various mRNA isoforms. Probe intensity is 
used to detect changes in exon expression levels (quantitative change) whereas 
existence of different exon-exon junctions in a gene signifies changes in gene 
sequence content (qualitative changes). When individual exon-exon junction probes 
are considerably down regulated relative to the other probe, those with statistical 
significance above a given threshold level are reported as alternative splicing 
prediction. 
Microarray analysis has made a significant contribution to the discovery of 
alternatively spliced variants of human genes. However, the method is limited by the 
fact that prior knowledge of gene structure (transcript) is needed before the 
experiment is done. Hence exon-exon junction microarray method is mostly used for 
identification of alteration in exon usage in different cells or tissues but not suitable 
for discovery of novel splice isoforms (Lee & Roy 2004; Clark et a/., 2007). Besides, 











exons corresponding to the 5' and 3' UTRs of mRNA. As a result, there could be 
limited identification of 5' and 3' alternative terminal junction using this method. 
Predominantly, microarray studies address only one type of alternative splicing, 
monitoring exon inclusion or deletion events that are tissue specific (Johnson, 2003; 
Kampa et al., 2004) and the other alternative splicing events (i.e. 5' and/or 3 
alternative splice sites usage) are not well studied (Lee & Roy, 2004). Furthermore, 
when analysing microarray data it might be difficult to separate the difference 
between transcript changes that are due to general gene expression from changes 
due to alternative splicing (Le et al., 2004). 
2.3.4.3 Alternative splicing databases 
The transcript derived alternative splicing predictions have made it possible to 
identify and characterize alternative splicing events on a genome-wide scale. The 
comparable nature of microarrays makes them most suitable for monitoring tissue or 
cell specificity of spliced isoform, while, ESTs are ideal for transcript structure 
prediction. The rate of alternative splicing recovery depends on available transcript 
coverage; hence, recent estimates may increase with the increase in transcribed 
sequence data available. 
Besides the prediction of alternatively spliced isoforms using transcripts sequences, 
a number of approaches use ab initio prediction (Phillips et al., 2004; Sorek et al., 
2005; Dror et al., 2005; Holste & Ohler, 2008). This computational approach is made 
possible by the fact that ASEs have different characteristics compared to CSEs. 
Thus, machine learning can be used to look for special sequence features 
associated with ASEs and CSEs. On the other hand, recognition of alternatively 
spliced variants can be achieved through comparative genomics approach by 
identifying alternative splicing events that are conserved with respect to orthologous 











Yeo et a/., 2005). This method is useful because it reduces prediction of non 
functional alternative splice patterns. 
Given the various ways in which datasets of alternative spliced genes are produced, 
it is now possible to obtain a catalogue of alternatively spliced genes and their 
mRNA isoforms. The information is stored in specialized alternative splicing 











Table 2.2: Databases of alternative spliced genes 
Tool Type of data Species Method Website Authors 
ASAPII Genomic sequences 15 species Comparison of DNA and http://www.bioinformatics.ucla.edu/ASAP2 Kim, et a/., (2007 
ASEs and CSEs EST-genome alignments 
ASD Alternative splice exons Human & Mouse Comparison of cDNA and httQ:llwww.ebi.ac.uk/asdl Stamm et 
EST-genome alignments a/., (2006) 
ASDB Genomic sequences Human & Mouse Clusters corresponding to httQ:I Ihazelton .Ibl.gov l-teQI itski/alU Dralyuk 
gene transcript variants a/.,(2000) 
ASG Splice Human Genome based splice httQ:I Istatgen. ncsu. ed u/asgl Leipzig et 
graphs,combinatorial graphs al., (2004) 
splice variants 
AsMamDB Alternative splicing Human, Comparison of GeneBank httQ://166.111.30.65/ASMAMDB.html Ji et a/., (2000) 
events Mouse,rat annotate splice variants 
ASPIC Gene and 17 species Comparison of httQ://LcasQur. iU ASPIC/ Bonizzoni et 
exon-intron EST -genome alignments al., (2005). 
stucture prediction 
EASED Alternative 9 species Comparison of ESTs with httQ://eased. bioinf. mdc-berlin.del Pospisil et 
splice transcripts mRNAs al., (2004) 
ECgene Gene and 9 species Genome based splice httQ:IIgenome.ewha.ac.kr/ECgene Kim et a/., (2005) 
transcript prediction graphs 
HOLLYWOOD Genomic annotations Human cDNA and genome httQ://holl~wood. miLedu/Logo/index. html Holste et a/., 
splicing patterns and Mouse alignments (2006) 
Splicelnfo Alternative splicing Human Comparison of mRNA-and httQ://sQliceinfo. mbc.nctu.edu. tw Huang et a/., 











2.4 Human Genetic Variation 
Having discussed transcript variation within an individual resulting from alternative 
splicing, we now turn to a discussion of genetic variation as a cause of transcript 
variation between individuals. Human genetic variation and our environment are the 
two basic factors that cause human phenotypic variation. Genetic variation arises 
through a spectrum of changes in a genome sequence, encompassing point 
mutations and chromosomal evolution. Genetic variation is natural and governed by 
biological, demographic and historical processes (Chakravarti, 1999). Notably, the 
genetic variation that has survived in the human population is non-random; it has 
been shaped by both genetic drift and natural selection. 
Although genetic variation takes many forms, the most common genetic variations 
found in the human genome are single nucleotide polymorphisms or SNPs 
(Altshuler et al., 2000). SNPs are heritable single nucleotide substitution, with the 
rare allele occurring at a frequency of at least 1 % within population. Note that the 
terminology for variation is defined by allele frequency, and in the strictest sense 
genetic loci are only regarded as polymorphic if the frequency of the uncommon 
allele is equal to or greater than 1 %. When a single base substitution occurs at less 
than 1 % it is considered to be a mutation. However, during the post genomic era this 
definition is often disregarded; instead "mutations" occurring at less than 1 % in 
general populations might be termed low frequency variations (Collins et al., 1998). 
SNPs can be bi, tri, or tetra allelic. SNPs are classified according to their genomic 
position and the nature of the nucleotide that is affected. Non-coding SNPs are 
located in either untranslated region (UTR), introns, or they may be intergenic. 
Coding SNPs are located within protein coding regions and may be non-
synonymous (they change amino acid that is encoded) or synonymous (they change 
the codon but not the amino acid). Non-synonymous SNPs usually influence 
structural and functional features of the affected proteins (Lucotte, 1998; Ramensky 











the coding capacity of a gene, they may affect gene function through their effect on 
gene expression regulation (Ramensky et al., 2002). SNPs occurring in coding 
regions or flanking regulatory sequences of a gene could have deleterious 
consequence on gene function and possibly cause disease (Stenson et al., 2003). 
SNPs are commonly used as genetic markers for finding the genetic basis of 
phenotypic variation in the human population. It is already known that expression of 
many genes varies significantly between individuals because of allele specific 
regulation (Oleksiak et al., 2002; Buckland, 2004; Knight, 2004). For example, Bray 
and colleagues (2003) showed differential expression in the human brain which 
occurs due to cis-acting genetic variations among individuals. Allele-specific 
regulation might also produce difference in disease susceptibility or manifestations 
between individuals (Eriksson et al., 1995; Montagna et al., 2002; Prokunina et al., 
2002; Miao et al., 2003,). 
Analysis of the effects of SNPs on gene transcripts has assisted in understanding 
the underlying causes of qualitative or quantitative differences in the way in which 
genes are expressed, the causes of differences in protein function among 
individuals. Table 2.3 provides currently available bioinformatics tools which provide 
analysis of genetic variation and their possible functional implications within the 
human genome. Similarly, these tools can be further exploited for evaluating the 











Table 2.3: Online SNP databases and related tools 
Tool Type of data Species Website Reference 
ColiSNPs Maps nsSNP on the 3D structure of 13 Organisms httQ://yayoi. kansai. jaea.go. jQ/colisnQ/ Kono et al.,(2008) 
proteins 
dbSNP Primary repository for SNP data 16 organisms httQ://www.ncbi.nlm.nih.gov/Qrojects/SNP/ Sherry et a/., (2001) 
F-SNP Functional effect of SNP Human httQ://comQbio.cs.queensu.ca/F-SNP/ Lee & Shantkay, (2008) 
HapMap SNP allele and genotype frequencies Human httQ://www.haQmaQ.org/ IHC, (2005) 
and Haplotype block 
HGMD Mutations associated with human Human httQ:/ /www.hgmd.ct.ac.uk/ac/index.QhQ Stenson et a/., (2003). 
inherited disease. 
HGVbase Genomic variation data of all types Human http://www.hgvbase.org/ Fredman et a/., (2002) 
(SNP, Indel, and Tandem Repeat). 
Neutral and disease related mutations 
JSNP Common genetic variation in Human http://snp.imsu-tokyo.ac.jp/ Hirakawa et a/.,(2002) 
Japanese population 
MutDB Intergration of genetic variation Human http://mutdb.org/ Singh et aI., (2008) 
with molecular features and clinical data 
PolyP hen Predict effect of nsSNP on protein Human www.bork.embl-heidelberg.de/PolyPhen/ Ramensky et a/., (2002) 
structure and function 
PupaSuiti Coding and non coding SNPs and Human, http://pupasuite.bioinfo.cipf.es/ Reumers et a/., (2008) 
SNPeffect mutations mouse & rat 
SNPtoGo Assign Go terms to SNPs in Human https://webtools.imbs.uni-Iuebeck.de/snptogo Schwarz et a/., (2008) 











2.5 Genetic variations that alter alternative pre-mRNA splicing 
We have already mentioned that the impact of a SNP on gene expression profile 
and protein function depends upon its location within the genome (Cargill et aI, 
1999; Hudson et aI, 2004). Genetic variations located at pre-mRNA splicing 
regulatory regions may affect the way in which genes are spliced, resulting in 
differential splice patterns which may play an important role in phenotypic diversity 
and genetic disorders between individuals (Faustino & Cooper, 2003; Nissim-Rafinia 
& Kerem, 2005). Some alternatively spliced variants occur between individuals 
instead of within individuals. For example, Figure 2.6 shows that a G to T single 
nucleotide polymorphism in donor (5') splice site of exon 14 of human serum 
albumin A (HSA) gene result in exon 14 skipping in certain individuals of Italian 
populations (Watkins et al., 1991). The protein product of the splice variant differs 
from normal albumin A. 
~ __ 1_3 __ ~~~ ____ 1_4 __ ~~~ ____ 1_5 __ ~ Normal albumin A 




Figure 2.6: Schematic representation of allele dependent alternative splicing. Exons are shown as 
boxes and introns as straight lines connecting the exons. The canonical donor and acceptor 
nucleotides for normal albumin A gene are shown above the line on the genomic DNA. The altered 
Venezia (Italian population) splice junction is shown below the line. The GIT SNP (shown in red) in 
exon14-intron14 junction inactivates selection of splice site and as a consequence, exon 14 is 











Cis-acting splicing regulatory single nucleotide polymorphisms (srSNPs) might be 
the underlying cause of distinct transcript patterns among individuals. Hence, before 
we attribute multiple transcript variants of a gene to alternative splicing, it is 
necessary to distinguish between transcript variant which are the result of true 
alternative splicing (same allele results in different splice patterns), possibly serving 
to increase the functional repertoire of a gene, and transcript variant resulting from 
genetic polymorph isms, which may be responsible for some phenotypic variation 
between individuals. 
Although there has been no systematic study showing the prevalence of 
polymorphism that affects pre-mRNA splicing, Nembaware et al (2004) estimated 
that 21 % of alternatively spliced genes found in alternative databases are allele 
specific alternatively spliced events. Therefore, some of the observed alternative 
splicing patterns are not a product of alternative splicing of a gene within different 
tissues of individuals but are due to polymorphisms that may be responsible for 
phenotypic differences between individuals. Efforts to identify allele dependent 
spliced transcripts in certain genes have been undertaken. Table 2.4 shows some 
experimentally validated genes that are affected by allele-specific splicing. 
In consideration of the fact that the current bioinformatics methods to detect 
alternative splicing rely absolutely on the assumption that pre-mRNAs are spliced in 
the same way in different individuals, it would be of great interest to conduct an 
investigation of the extent to which genetic polymorphisms affect splicing. This is a 
topic of Nembaware et al. (2004; 2008) work and this thesis will contribute towards 
developing methods to detect allele-specific splicing in human by looking at how 











Table 2.4: Allele-Specific Alternatively Spliced Genes and Associated rSNPs 
Gene Exon affected rSNP Cis-element References 
C3AR1 Exon 2 rs2230318 Unknown, located Hasegawa et al., 
exonic region ( 2004) 
CAST Exon 10 rs7724759 5'ss Kwan et al., (2007) 
CD45 Exon 4 rs12129883 ESS Jacobsen et al.,( 2002) 
COL5A1 Exon 65 rs13946 3'ss Wenstrup et al., (1996) 
ETV4 Exon 3 rs3765174 NAG NAG acceptor Hiller et al.,(2006) 
GABRR1 Exon 2 rs4590242 NAG NAG acceptor Hiller et al., (2006) 
GSTM4 Exon 4 and Exon 5 rs560018 3'ss Denson et al., (2006) 
ITPA Exon 2 and Exon 3 rs13830 ESS Arenas et al.,( 2007) 
LDLR Exon 12 rs688 ESE Zhu et al., (2007) 
MST1R Exon 19 rs12489386 Unknown, located Angeloni et al., (2003) 
intronic region 
MUC1 Exon 2 rs4072037 Unknown, located Ligtenberg et al., (1991) 
exonic region 
OAS1 Exon 7 rs10774671 3'ss Bonnevie-Nielsen et al. 
2005) 
PARP2 Exon 2 rs2297616 5'ss Kwan et al., 2008 
PMM2 Exon 5 rs28938475 ESE Vuillaumier-Barrot 
al.,(1999) 
RBM23 Exon 6 rs2295682 Unknown, located Hull et al.,( 2007) 
exonic region 
TAP2 Exon 12 rs241447 Unknown, located Qu et al., (2007 ) 
exonic region 












EXON ANNOTATIONS AND SNP DATASETS 
3.1 Overview 
A major objective of this chapter is to describe the methods used to generate human 
exon and SNPs datasets, which are further used for analysis. The current 
investigation is based on the Human genome assembly (NCBI 35). We will exploit 
exon information from the Ensembl and ASAPII databases whereas the SNP 
dataset is derived from dbSNP and HapMap. All these datasets are accessed from 
either interactive website or MySQL database servers via the internet. 
3.2 Background 
The complete sequence of the euchromatic portion of the human genome is 
available for analysis (Lander et al., 2004). The genomic data comprises 
approximately 3 billion base pair sequence and the associated annotations which 
are stored in database systems (Lander et al., 2001; Venter et al., 2001). As we 
already cited in Table 2.2 and Table 2.3, databases are core resources of 
Bioinformatics because they offer a convenient and efficient method of storing and 
mining vast amounts of genomic data. There are numerous biological databases, 
depending on the nature of the information being stored. Our challenge is to make 
sure that the raw genomic data found in the databases is transformed into biological 
meaningful information applicable in health science research. 
The Ensembl database is a system which provides automated genome annotation 
and tools for the visualisation of annotated genomes. For this project, the Ensembl 
database is the source of annotated human genome sequence, with confirmed and 











(Hubbard et al., 2005). We chose the Ensembl system for the exon dataset because 
it provides genomic mapping of exon-intron gene structure together with EST 
confirmed transcripts. In addition to Ensembl, we used ASAP II to characterize 
alternatively and constitutively spliced exons. ASAPII is a comprehensive database 
of alternative splice variants predicted from ESTs and mRNA data (Kim et al., 2007). 
In ASAPII, the genome-wide manual annotation of alternative splicing events is 
presented with tissue specific and comparative genomics information. 
To develop a genome-wide catalog of sequence polymorphisms that are found close 
to intron exon boundaries, we used the NCBI database of Single Nucleotide 
Polymorphisms (dbSNP) which contain approximately 10 millions human genetic 
sequence polymorphisms (Sherry et aI., 2001). dbSNP provides data on human 
genetic variations that can be easily mapped to exon-intron junctions. We also 
obtained SNP allele frequency information from the HapMap database (Altshuler et 
al., 2005). HapMap contains genotype and population specific allele frequency data. 
3.3. Materials and Methods 
3.3.1 Exon dataset 
We obtained pre-computed genomic coordinates (strand, chromosomal start and 
end positions) for all annotated human exons from the Ensembl MySQL Homo 
sapiens core database (version 36.35i). 
The data can also be downloaded through the Ensembl genome browser, 
http://dec2005.archive.ensembl.org/index.html, released in December 2005. 
Ensembl gene annotations can include exons from pseudogenes and very short 
exons « 20bp). We removed these from the dataset. 
3.3.2 Classifying exons as alternatively and constitutively spliced 
We downloaded MySQL tables (files) from a database of alternatively spliced 











released in January 2006. ASAP II provides genomic mappings of alternatively and 
constitutively spliced exons. To identify Ensembl alternatively spliced exons, we 
used chromosomal locations of the ASAPII annotated alternatively spliced exon 
dataset. By default, we consider every Ensembl exon as constitutively spliced 
unless its corresponding ASAPII exon annotation is alternatively spliced. This 
method produced a dataset of alternatively spliced exons with both Ensembl and 
ASAP II identifiers. Using this approach we produced a dataset of 25 086 
alternatively spliced exons (ASEs) and 215 833 constitutively spliced exons (CSEs) 
which we used for further analysis. 
For several reasons, the number of alternatively spliced exons identified might be an 
underestimate. Firstly, the total number of ASAPII annotated exons is a little more 
than half the total number of Ensembl annotated exons. Ensembl gene structure 
annotation uses a combination of ab-initio gene prediction algorithms, evidence from 
various external sources (Le. homologs) together with transcript (Le. ESTs, cDNA) 
genomic alignments, whereas ASAPII annotation uses only transcript alignments. 
Consequently a majority of Ensembl annotated exons are not found in the ASAPII 
dataset. Secondly, our method of alternatively spliced exon prediction could have 












3.3.3 SNP genotype and frequency dataset 
We retrieved human SNP data from the Ensembl MySQL server. We used human 
variation data from the Ensembl Homo sapiens variation database (version 36 35i) 
which is based on the NCBI dbSNP build 125. Only the RefSNPs (rs) annotated by 
the NCB I on reference genome sequence contigs were included for analysis. 
dbSNP contains single and poly nucleotide polymorphisms in addition to short 
deletion/insertion (indels) polymorphisms. SNP locations on human chromosomes 
are catalogued together with possible nucleotide character states (alleles). Our 
analysis include all RefSNPs found in dbSNP, Hence we use the term SNPs for all 
the different types of genetic sequence variation as annotated in dbSNP. 
Although dbSNP is considered a comprehensive database of genomic variation the 
quality and completeness of dbSNP data has been under scrutiny lately (Reich et 
al., 2004; Platzer and Hiller, 2006). To avoid including sequencing errors submitted 
to dbSNP we also considered and used a subset of validated SNPs from the 
dataset. In dbSNP, a polymorphism is categorized as validated only if the 
submission was validated by a non-computational method, and/or has frequency or 
genotype data submitted (i.e. HapMap). 
3.4 Results and Discussion 
3.4.1 Human exons 
We retrieved all available human coding exons from the Ensembl genome database, 
most of which come from multi-exon protein coding genes. Genome-wide analysis of 
the human genome sequence indicates that the genome contains approximately 25 
000 genes with each gene having an average of 8-10 exons (Thanaraj & Stamm, 
2003). This is supported by our dataset of human genes and exons described in 
Table 3.1. The median exon length is 134 bps although there are shorter and much 
longer exons in the dataset (Table 3.2). Previous studies of statistical features of 











genes (Zllang, 1998). According to our distribution of emn lengtils we assumed that 
bolll internal al1d terminal exons are included in our analysis. 
Table 3.1 : Descriptive summary for Ilum811 genes and exon 
Genomic Features Total No. 
Protein codinQ genes L2 L18 
RNA coding geM" ~ 133 
Average numbBf of exons per gene 10 
Em", 240918 
Exons from protein codirtg QOO€S 236785 
hons lmm RNA 9fmes 4133 
Table 3.2: Distribution of human exon length 
3.4.2 CSEs vs. ASEs 
We fUrlher categorized Ensembl exoll as either constitutively spliced or alternatively 
spliced. Using Ensembf and ASAPII annotation we identified 25 086 oul of 240 918 
exons as alternatively spHced. Tile two exons categories 11811e distinct lengths. The 
average length of alternatively spliced exons (ASEs) is not much more Ulan half that 
of constitutively spliced exons (CSEs) (Figure 3.1). The exon length variation 
between ASEs and CSEs might be due to either functional evolutionary constraints 
imposed on internal skipped exons to keep them sllort and/or existence of partially 











The results concur with previous reporls which show that alternatively spliced exons 
are significantly shorter than constitutively spliced exons (Stamm, 2000; Zheng 81 
al., 2005). Suggestions have been made thai the length of al ternatively spliced 
exons (Black, 1991), as well as the length of its flanking introns (Bell 81 aI., 1998) 
are involved in alternative splicing regulation. 
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Oistribution of ex on length 
, 
m 
Figure 3,1 [lox plot showing dislribulioo 01 conslilulive ly splk:ed exon (CSE) and allernatively 
spliced exoo (ASE) lenglhs. The dala consists or 169 001 eSEs and 25 086 ASEs. AllernatNCly 
spliced ewns are shorter (mean = 158. SD = 220) lhan cooslilulively splk:ed exoo (me"" ~ 266, SD 
= 5(4). The Mann-Whitney U lest indicatcs a highly significanl (p < 0.0001) difference belween lhe 
lWo medians_ 
There are several possible explanations for why alternatively spliced exons are 
shorter than constitutively spliced exons. Firstly, exons thai are shorter lhan an 
average exon length have a tendency to code in more than one reading frame 
(Clark and Thanaraj, 2002), implying tilal short exons can contribute 10 protein 
diversity (Liang & Landweber, 2007). Secondly, reduction of the long constitutively 











(Dominski & Kole, 1991). In addition, Chern (2006) anticipated that the short 
alternatively s~iced exons observed are basically long constitutively s~iced exons 
with cryptic s~ice sites, which can be alternatively spliced to produce shortened 
exon of varied length (Figure 3.2). 
1 1 1 
Cl ________ ~ __ ----_-·~I ~ 
'-----------~------~-' 
Figure 3,2: graphical representations 01 possible splice patterns 01 long constitutio,"y Sr>iCM e,ons 
cantaining cryptic sr>ir;e ~ile s. Long emns {greeni are like~ ta harbor cryptiC sPlir;e site~ (ind",,,ted 
by arraw) and the activation 01 crypt;: donor and acceptor spl'.:e sites induce alternative splicing, 
resulting In shortened e,ons wMo~e icr.cJth ~"ric~ I:>ctween tran""'pts, 
A recent study demonstrated that alternative 5' and 3' splice sites exons are an 
intermediate state between constitutive and alternative cassette exons. where the 
constitutive side resembles constitutive exons, and the alternative side resem~es 
alternative cassette exons (Koren et al., 2001). Th is model suggests that indeed 
alternatively spliced exons originated from constitutively spliced exons that acquired 
a new competing splice site during evolution This is clearly demonstrated by 
activation of the cryptic donor splice site in exon 17 of OPAl gene which results in 











shorterled alternative eXQn. The observed ASl:s sizes support the idea thai in 
additiorl to the common exon skipping events, many alternatively spliced exons are 
truncation events rather than extensiorls (Clark & Thanaraj, 2002) The decreased 
alternatively splicccJ eXOrl size migll! be a reflcctiorl of high prevalence of short 
skipped and truncated cxon events. 
3.3.2 SNP dataset 
We retrieved human variat iorl dClla across the gerlOllle and obtained genotypes 8rld 
allele frequerlcies. Tile majority of pdymorphisills fourld in dbSNP are bi-allclic 
SNPs, although p~y- (tri arid tetra) allelic SNPs and small insertions-deletiorls 
(indels) polymorphisms also exists (Table 3.2). In tile 11Umarl genome tri-allelic arid 
tetra-allelic polymorphisms arc said to be rare almost to the poirlt of non-existence 
(Brooks, 1999), yet we found 42 296 poly-allelic RcfSNPs indudirlg 12 280 validated 
SNPs in dbSNP. Our worning definition of SNP is single base pair polymorphism at 
which different alleles exists in the populatiorl. Hence, iOOels were not included irl 
the validated SNP dataset. 
















Data obtained from the Ensembl, ASAPII, dbSNP and HapMap databases allowed 
us to create a catalog of human exons and SNPs. All datasets used are based on 
NCBI Genome assembly 35, making it easy to integrate them. The information 
includes the genes to which the exons and SNPs are mapped, including the 
chromosomal positions and strand on which the exons and SNPs are located. The 
generated datasets allowed the survey on the prevalence of SNPs in the exon-intron 












PREVALENCE OF SNPS AT EXON-INTRON 
JUNCTIONS 
4.1 Overview 
This chapter aims to estimate the prevalence of SNPs at exon-intron junctions of 
human genes. We address the objective by carrying out a survey of the occurrence 
frequency of SNPs at exon-intron junctions using the human genome annotations 
described in chapter three. We also compared the distribution of SNPs at coding 
exonic regions and non-coding intronic regions flanking the exon boundaries. The 
data sets of ASEs and CSEs allowed us to estimate and compare the frequency of 
SNPs found in exon-intron junctions of the two exon categories. This genomic 
mapping of SNPs is likely to produce a dataset of SNPs which might affect mRNA 
splicing. 
4.2 Background 
Alternatively spliced exon patterns from a single gene might be a result of either 
tissue specific alternative splicing events within an individual (Gravely, 2001; Kan et 
al., 2001) or due to occurrence of splicing regulatory polymorphisms that affect the 
way in which genes are spliced in different individuals (Hull et al., 2007; Kwan et al., 
2007; Kwan et al., 2008). Earlier studies estimated that 21 % of alternatively spliced 
genes are affected by polymorphisms that affect splicing (Nembaware et al., 2004). 
Besides, several experimentally validated examples of genes with alternatively 












Most of the carefully studied splicing regulatory SNPs that are associated with 
alternatively spliced exons are cis-acting (Angeloni et al., 2003; Kralovicova et al., 
2004; Hiller et a/., 2006). For example a C to an A single nucleotide polymorphism 
found in intron 18, 10bp upstream of acceptor splice site of exon 19, of the MST1 R 
gene is associated with skipping of exon 19 (Angeloni et al., 2003). There are 
instances where the SNPs are found at undefined positions and operating through 
trans-splicing regulatory factors (Vithana et al., 2001; Horiuchi et al., 2003). Some of 
the splicing regulatory SNPs are found in generally healthy populations; however 
there are cases of aberrantly spliced exon patterns leading to diseases that have 
been shown to arise from SNPs that modulate alternative splicing (Mukai et al., 
2004; Krawczak et al., 1992; Hiller et al., 2006; Krawczak et al., 2007). 
Identifying human genetic variations that are the basis for heritable phenotypic 
variation is still a developing research field. In line with aims of the International 
HapMap Consortium (Altshuler et al., 2005). identifying functionally important 
variation in the human genome has the potential for increasing our understanding of 
gene function and for providing markers to study the effect of genetic variations in 
gene expression and human disease risk. Similarly identifying genetic variation 
found at splicing regulatory regions that have been associated with phenotypic 
variation is important for understanding the relationship between splicing and human 
disease susceptibility (Hull et al., 2007). 
A critical examination on how SNPs are distributed in the exon-intron junction can 
assist in finding regulatory polymorphisms that affect splicing. However, it is difficult 
to figure out how pre-mRNA splicing is affected by genetic polymorphisms without 
availability of expression data. We expect that identification and estimation of the 
prevalence of SNPs at exon-intron junctions will provide insight into polymorphisms 
responsible for heritable phenotypic differences within the human population and 












4.3 Materials and Methods 
4.3.1 Defining genomic exon-intron junctions 
Genomic mapping of exon-intron boundaries in human genes were based on 
Ensembl gene annotations which provided the chromosomal start and end positions 
of the exons, Here. we use the term exon-intron junction or sp lice junction 
interchangeably, to refer to the 60bp region flank ing the 3' and 5' intron boundaries 
(Figure 4.1). Our investigation focused on th is reg ion because it is where most of the 
known cis-acting splicing regulatory sequences are sited (Mount, 1982: Tian & 
Maniati s, 1994: Bu rge et al .. 1999: Brudno et al., 2001). 
(A) 
(B ) 
tt"~,g, ga='~'h'gttt_c:tttggtttcttc:tc"c,...cCCGTTA Tn !lCT ACCT,¥;TGAAAnlGrr,crCTcm 
GGCTATGAGGATAGGAGATGGGAGCTN'MGA.AGATGTTGA TGAGGGCMGA TTCGAGAA TTTAAAC(;'>AnCA 
(;T('-AA(;GCACCGA(""'GTCAAAAGGGTGgl""Jt>Clttlgo'"""'gt""'''''J'Je'''Clt3ao;la.lot~'"''' ' tttttte,,,, 
• • • • 
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Figure 4,1 IIlustrahon ar genamic m~pring af exon-introo junclions (AI Genomic sequeDce of exoo 
10 (ENSEO()(]OO9J0049) ~nd GOnl fi,H)king in lronic sequences of the CHD8 gene Exo~ S"'1uenee~ 
(' 38 nj) "re shown in upper cases aDd intronie s"'1LJences are ~how~ in lawer ca~es wilh S' Jnd 3' 
splice sites dinucloot<fes highl>ghH>d in Qroon. Blue highlights the exon-intron junct >:ln near acceptor 
(3') splice site~ and red hi9h li9hts exoo-introo junetioo near donor (S') splice sites , (8) Gr"phic,,1 
repre~eDtation of the emn (t>a.) ,,,'id Mi,,'iklng Inlrons ( ~ nel with 5' "nd 3' splice ~ites dinucleotide 
h>ghlightad in green, S kJ e "nd red doobl e "rrow shows genom'le mapping of exon-intron jLJr)ctions 
fl~nking the 3' "nd S' i~tron bou~da"es. respectioety Chromosamal loc"tlon or the emns is shown 











4.3.2 Frequency of SNPs in the exon-intron junctions of human exons 
Both exon and SNP annotations were based on NCBI 35 genome assembly, which 
enabled us to easily map the SNPs to the splice junctions. We initially used all 
annotated SNPs (RefSNPs) to estimate the distribution of polymorphisms as a 
function of distance from exon-intron junctions; however, we later considered a SNP 
dataset with only validated entries. We inspected the human genomic DNA for 
occurrence of polymorph isms in the entire ±60bp sequence flanking the exon 
boundaries. We further compared the distribution of SNPs between the exon-intron 
junctions of CSEs and ASEs. A combination of SOL and PERL scripts were used to 
download and store the data. PERL scripts were also used to compute the 
frequency of occurrence of SNPs as a function of distance from the exon 
boundaries. 
4.3.3 Statistical analysis of SNP distribution at ASEs and CSEs 
We compared the frequency of SNPs at exon-intron junctions of alternatively spliced 
exons (ASEs) and constitutively spliced exons (CSEs). Data from the survey were 
entered into Microsoft Excel and then imported into R statistical computing software 
version 2.1.1 (Ihaka & Gentleman, 1996) for analysis. We used chi-square test to 
compare the proportions of SNPs in the two groups, to test whether is there a 











4.4 Results and Discussion 
4.4.1 Frequency of SNPs in the exon-intron junctions of human exons 
To estimate the prevalence of SNPs at exon-intron junctions of human genes we 
computed the SNP frequency distribution based on the observed occurrence of 
polymorphisms as a function of distance from the exon boundaries. A total of 47036 
SNPs were found at splice junctions of approximately 40 000 exons from 14 921 
Ensembl genes. This is approximately 1 % of total validated SNPs found in dbSNP 
(version 125). This number might be an under estimate because of stringent filtering 
during SNP identification and genotyping. Of the identified SNPs, 23 367 were found 
in the exon-intron junctions near the donor splice sites (Figure 4.2a and Figure 4.2b) 
whereas 23 669 were found in the exon-intron junctions near the acceptor splice 
sites (Figure 4.2c and Figure 4.2d). There are few cases where a SNP maps to both 
5' and 3' splice junctions of different exons possible due to it being found in splice 
junctions of two exons separated by an intron shorter than 60bp in length. 
The splicing regulatory sequences flanking the 3' splice site are more complex than 
near the 5' splice sites, largely due to additional sequence constraints required for 
recognition of acceptor splice sites compared to donor splice sites. We would then 
expect lower prevalence of SNPs around the genomic region near acceptor splice 
sites compared to the regions near splice donor sites. However, we detected no 
significant difference in the average number of SNPs located in the splice junction 
regions near 5' splice sites compared to near 3' splice sites even when only 
validated SNPs were used for the analysis (p = 0.1591). The reason might be even 
though the genomic regions harboring the 5' splice sites are shorter and less 
complex than regions defining 3' splice sites they are similarly important in the 
regulation of splicing. According to the established "exon definition" model of splice 
site selection during pre-mRNA splicing, interactions of the spliceosome 
components with the 5' end of the exon initiate the splicing reaction in vertebrate 











distributions of SNPs in the splice junction regions near 5' splice site compared to 
near 3' splice site 
We observed that the average number of SNPs at exonic regions of the splice 
junctions near the donor splice sites is lower than the average number of SNPs at 
the intronic regions when using both validated SNPs and all RefSNPs datasets (p= 
7.269 x 10-13 , P =6.785 X 10-13, respectively).The same results were observed when 
considering the splice junction near the acceptor splice site using both validated 
SNPs and RefSNPs entries (p= 1.251 x 10-13 , 5.882 x 10-12 respectively). The 
significance of the observed difference between the average numbers of SNPs at 
the intronic verses exonic regions was assessed using a student t-test. These 
results are in agreement with previous findings showing that coding regions have 
less sequence variation than non-coding regions due to functional constraints in 
coding regions (Balasubramanian et a/., 2002; Zhao et a/., 2003). 
We extended the analysis by looking at the distribution of SNPs within the coding 
parts, the exonic region, of the splice junction. We observed that SNPs occur less 
frequently near the splice sites positions and the frequency of SNPs become 
relatively higher as we move away from the splice site positions. The number of 
SNPs per site portrays the site variability. The higher the number of SNPs in 
genomic position, the less conserved is the position. Our observations support 
findings which suggests occurrence of conserved exonic splicing regulatory 
sequences (i.e. ESE) at highest frequency near exon boundaries, and less 
frequently as you move away from the exon boundaries (Majewski & Ott 2002; 
Fairbrother et a/., 2004). In addition, there is also evidence of codon usage bias for 
amino acids that occur frequently in exonic splicing regulatory motifs (i.e. ESE) near 
the exon boundaries (Willie & Majewski 2004; Parmley & Hurst, 2007). Therefore, it 
is likely that many nucleotide substitutions that occur close to exon boundaries are 
under selective pressure to conserve the pattern and function of splicing regulatory 











We also observe that the donor (GT) and acceptor (AG) splice sites dinucleotides at 
positions +1, +2 (Figure 4.2b) and -2, -1 (Figure 4.2d) respectively have the lowest 
occurrences of SNPs compared to the other positions in the splice junctions. 
Approximately 333 validated SNPs are located in the canonical 5' and 3' splice sites 
from 330 Ensembl annotated exons were identified. A number of these SNPs might 
alter RNA splicing patterns, consequently causing disease. For example the 
acceptor splice SNP (rs1 0774671) found in the 2',5' -oligoadenylate synthetase 
(OAS 1) gene is strongly associated with susceptibility to viral infection (Bonnevie-
Nielsen et al., 2005). The decreased frequency of SNPs in the intronic dinucleotides 
positions compared to exonic regions reflects the more severe effect of splice site 
mutations on gene function compared to non-synonymous mutations that alter 
individual amino acids. As a result, the occurrence of polymorphisms in the coding 
regions is better tolerated than in the splicing regulatory sites. 
While there is significant evidence of nucleotide conservation in splice site regions, 
deviation from consensus splice sites naturally exists among human introns (Burset 
et al., 2000; Tanaraj & Clark, 2001). For example, an analysis of splice sites in 
mammalian genomes showed consistent exception to the GT -AG rule where AT -AC 
and GC-AG splice site pairs are observed (Burset et al., 2000). These cases 
demonstrate normal transcript expression patterns. We observed an increased 
occurrence of SNPs at guanine positions of both splice sites. This is mostly 
observed when all dbSNP entries are used although the validated SNP data also 
shows the same SNP distribution. These observations were not expected since 
these positions determine the splice sites marking the intron boundaries and are 
believed to be highly conserved. According to Vorechovsky (2006) the higher 
number of polymorphisms in the G than A splice acceptor position is mainly due to 
the higher proportion of AG creating mutations (cryptic splice sites). We assume the 
increased occurrence of SNPs at guanine (G) positions of the splice donor and 
acceptor sites suggest that the most frequently introduced base is guanine during 
splice site creation. However, we also acknowledge that there might be no biological 











intron ends rather than sequencing errors in some of the SNP entries submitted in 
dbSNP as suggested by Platzer and Hiller (2006). 
Out of the 47 036 SNPs located in the exon-intron junctions, we identified several 
examples where the SNP alleles have already been associated with alternative 
splice patterns, thus contributing to transcript variation among individuals. These 
include a SNP (rs4072037) in exon 2 of episialin gene (MUC1) which results in 
activation of cryptic splice site eight nucleotides downstream of the canonical 
acceptor splice site (Ligtenberg et al., 1991). The naturally occurring allelic 
differences of the SNPs dictates the choice between the two acceptor splice sites, 
consequently two splice variants of the exons are produced. Other examples include 
alleles at exon-intron junctions of RNA binding motif protein 23 (RBM23), transporter 
2 ATP binding (TAP2), Poly [ADP-ribose] polymerase 2 (PARP2) CD 46 antigen 
(CD46), endoplasmic reticulum aminopeptidase 2 (ERAP2), and interferon 
regulatory factor 5 (IRF5) genes which also favors different splicing isoforms (Hull et 
aI., 2007; Kwan et al., 2008). All these examples are in contrast with other 
alternative splice events that are either developmental or tissue regulated. 












RefSNPs at 5' Splice Junction 
~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ 
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4.4.2 SNP distributions in the exon-intron junctions of CSEs and ASEs 
We categorized the Ensembl exon dataset into constitutively spliced exons (CSEs) 
and alternatively spliced exons (ASEs), and then computed the frequency 
distribution of SNPs as a function of distance from the exon boundaries. There were 
no SNPs which mapped to exon-intron junctions of both CSEs and ASEs in the 
analysis. We observed that generally ASEs have lower frequencies of occurrence of 
SNPs at their exon-intron boundaries with higher conservation of splice site 
sequences compared to CSEs (Figure 4.3a and Figure 4.3b). P-values, with Yates' 
continuity correction, were determined using chi-square test (Table 4.1 a and Table 
4.1 b). We considered p-values less than «) 0.05 as indicative of statistical 
significance. Nevertheless there may possibly be no significant difference between 
the frequencies of SNPs in the exon-intron junctions of these exons category. There 
are genomic positions which show a higher rate of occurrence of SNPs at ASE 
junctions than the corresponding regions in CSEs. Such observations are seen in 
genomic positions found more than 40bp away from the donor splice site (Table 
4.1a). 
Our findings are in some way contradictory to what has already been suggested for 
ASEs, that ASEs are relatively short and are more tolerant of polymorphisms at their 
splice site and are influenced by weak selective constraints than CSEs (Dye et a/., 
1998; Stamm et a/., 2000; D'Souza & Schellenberg, 2002; Clark & Thanaraj, 2002). 
Indeed our dataset of ASEs have relatively shorter exon length, however they have 
fewer SNPs on splice sites and displaying increased exonic and flanking intronic 
sequence conservation compared to CSEs. The latter is a characteristic that has 
only been associated with conserved alternatively spliced exons (Sorek & Ast, 2003; 
Baek & Green, 2005, Yeo et a/., 2005). These results might be an indication that our 
ASEs dataset is composed mostly of conserved ASEs with relatively few human 
specific ASEs. Alternatively, the results might be an indication that generally ASEs 
are flanked by conserved sequence features subjected to more functional 











ASEs compared to boundaries of CSEs supports enrichment of conserved exonic 
splicing regulatory motifs in ASEs compared to CSEs. Intronic splicing regulatory 
elements associated with tissue specific splicing factors have been observed at 
higher density near conserved ASEs than CSEs (Brudno et aI, 2001; Voelker & 
Berglund, 2007; Yeo et al., 2007). 
Our observations draw attention to the possibility that the various types of ASE have 
diverse regulatory mechanisms and evolutionary paths (Mondrek & Lee, 2003; 
Zheng et al., 2005; Chern et aI., 2007); consequently they are characterized by 
different biological properties and features. It is possible that the discrepancy in the 
observed frequency of SNPs between the splice junction of ASEs and CSEs from 
what has already been found (Stamm et al., 2000; Clark & Thanaraj, 2002; Yeo et 
al., 2005) is due to the different types of ASEs having different patterns of SNP 
distribution in their splice junctions. For example, complex and simple ASEs might 
have contrasting frequency of SNPs in their exon-intron junctions compared to 
CSEs, as they have opposing selection pressure to preserve protein reading frame 
(Chern & Chaung, 2007). Apart from the two specified exon categories, CSEs and 
ASEs, it was necessary to further specify the splicing pattern of ASEs studied before 
we conduct a conclusive analysis of the frequency of SNPs at exon-intron junctions 
of ASEs compared to corresponding regions of CSEs. Therefore, we suggest that 
without consideration of the distinct ASE patterns comparison of the prevalence of 
SNPs at exon-intron junctions of ASEs with CSEs will allow only tentative 
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Table 4,1a' Analys is of SNP density at 5' splice junctions of ASEs and CSEs 
Genomic Position (nt) Exon Type RefSNPs Validated SNPs 
Prop.ortion p.v,lue Pmportion _I p-value 
, 
---6010-41 Constitutive O_06Oll '" 0_05 0_0279 ~ O.O~ 
-------- - -
Alt~rn.tive 0.0503 0.0212 
-4010 " ConstitutIve 0_05513 < 0_05 00270 <: 005 
Alternative 0.0468 , 0.0208 
-------- --- -- , -----------
-2010-1 ' Constitutive 0,0516 '" 0_05 0,0253 ~ 0,05 
- - -
Alternative 0.0428 i 0.0214 
1 lO 20 COrlS(itutive , 0,0642 ~ O.O~ I 0,0324 '" 0.05 , 
Alternative 0,0550 0,0308 
-- ---- -------- --- ------
21 to 40 CDI1stitutivc 0,0707 <Q,()5 O.Q3r~ < 0,05 , , ------- - - -----
j Alternative 00643 0_0353 , -----
41 loGO I C"",lilutiyc 00&139 ~ 0,05 0,0365 '" 0_05 
l 
Alternative 0.0677 , 0.0384 : 
Table 4.1b: Analysis of SNP denSity at 3' splice junctions of ASEs and CSEs 
Genomic Position (nt) Exon Typ~ RefSNPs - - -Va'iidaie,i"SNPs , 
Prop[)rtk>n p.y"Ju~ Proportion i p-va tue 
-60 to " Constitutive 0.0703 < 0.05 ; 0.03M <: 0.05 --_._-- ! 0.0340 Altcrn8tive t 0.0627 
, , 
-40 to " Constilutive 0.0677 '" 0_05 0_0353 ~ O.O~ 
Alternative 0,0606 0.0317 
-_._._--_ .. ---- ----
-20 to-I Constitutive 0.0626 < 0.05 0,0317 < 0,05 
-----
Altern.llve 0_0~36 0.0280 
----_.-
1 lo 20 ConstitutNe 0.0513 '" O_O~ 0.02fj~ ~ O.O~ 
Alternative 0.0399 0.0191 -_._-_ .... - ----- - -- , 
21 to 40 , Constitutive 00570 ~ 0.05 0,0281 < 0,05 
Alternative 0.0451 0_0192 
- ----_._.- _._--
41 toGO Consli lutive 00597 ~ 0.05 0.02B8 ~ 0.05 












Approximately 1 % of the total validated SNPs in dbSNP are located within ±60bp of 
exon - intron boundaries of human genes. The SNPs are mostly located in the non-
coding intronic regions rather than the coding exonic regions. We expect the 
conserved exonic regions have fewer SNPs due to purifying selection which 
prohibits occurrence of deleterious SNPs in functional regions. The donor (GT) and 
acceptor (AG) splice site dinucleotide positions, defining the intron terminals; have 
the lowest prevalence of SNPs in the exon-intron junctions. 
We observed that ASEs have lower proportions of SNPs in their exon-intron 
junctions than the CSEs. The difference in the proportion of SNPs within exon-intron 
junctions of ASEs compared to CSEs is highly significant. Nevertheless, these 
results might be influenced by sampling bias of data from the survey. It is almost 
impossible to directly predict the alternatively spliced exon patterns associated with 
each SNP in the exon-intron junction, using only genomic sequences. A number of 
SNPs in our dataset have already been experimentally validated and associated 
with allele specific splicing in human protein coding genes. These include RefSNPs, 
rs2297616 and rs2295682, found in exon-intron junctions of PARP2 and RBM23 
genes, respectively. It is highly possible that numerous SNPs found in exon-intron 
junctions of ASEs affect the way in which mRNAs are spliced, thus, contributing to 
alternatively spliced transcript patterns. 
We suspect the difference between proportions of SNPs in splice junctions of CSEs 
and ASEs might be, to a certain extent, due to limitations in our method of 
annotating the exons which contribute to large difference between sample sizes of 
the two exon categories. Alternatively spliced exons are annotated based on 
availability and/or representation of exons in sequenced transcripts and our method 
did not distinguish between the various types of ASEs. It is possible that many of the 











currently available transcripts (i.e. ESTs or mRNA) in the ASAPII dataset to indicate 












ANALYSIS OF FREQUENCY SPECTRA OF SNPS AT 
EXON-INTRON JUNCTIONS 
5.1 Overview 
This chapter aims to understand the role of natural selection in shaping the 
distribution of SNPs at exon-intron junctions of human genes. It addresses the 
objective by using the derived allele frequency (OAF) distribution. We used SNP 
allele frequencies from the HapMap database to compare the derived allele 
frequency distribution between SNPs located in exon-intron junctions, coding non-
synonymous sites, coding synonymous sites and SNPs located in non-coding 
regions. We further compare the OAF spectrum of SNPs located in exon-intron 
junctions of constitutively spliced exons (CSEs) and alternatively spliced exons 
(ASEs). Analysis was done using SNP frequency data from populations of Asian, 
European and African descent. 
5.2 Background 
Advances in the human genome project (Lander et al., 2001; Venter et al., 2001) 
and its subsequent analysis (Zhoa et al., 2003; Majewski & Ott, 2002) have shown 
that SNP density varies in different regions across the human genome. The rate of 
accumulation of genetic variation has been shown to vary significantly between the 
various regions of the human genome, such as protein coding regions, non-coding 
regions, exon, introns, and flanking gene expression regulatory regions 
(Chakravarti, 1999; Serre & Hudson, 2006). Non-coding intronic DNA harbors a 
much higher number of SNPs than the functionally important coding regions. 











frequency of SNPs at exon-intron junctions (Figure 4.2a-d). A recent study on 
conserved verses non-conserved nucleotide positions between human and non-
human primates showed that nucleotide diversity within conserved non-coding 
sequences is reduced compared with species specific non-coding sequences 
(Asthana et al., 2007). Therefore, SNP distribution in various regions of the human 
genome is not random, it follows specific patterns, depending on functional 
constraints on sequences, with coding non-synonymous sites reported to be less 
variable than non-coding regions (Cargill et al., 1999; Hughes et al., 2003). 
More than one allele (nucleotide variant) may be present at a locus, and the 
proportion of an allele in a population is referred to as the allele frequency (Li, 
1997; Nei & Kumura, 2000). Allele frequencies change over time due to random drift 
and/or the relative fitness of the alleles (Hartl & Clark, 1997). The latter means that a 
SNP allele associated with disease is expected to be kept at low frequency in a 
population (assuming that the disease phenotype leads to reduction of fitness) 
whereas an allele that serves to increase the fitness of the organism is likely to 
increase in frequency over time. The strong conservation of functionally important 
genomic regions and selection of alleles based on fitness in the genomic DNA is 
evidence that various regions of the human genome are subjected to natural 
selection more than other regions, and this contributes to variation in SNP 
distribution among the different regions of DNA. 
Random mutation and natural selection are both believed to be determinants of 
pattern of SNP distribution in the human genome by altering the allele frequency 
distribution in a population (Lercher et al., 2002; Fay & Wu, 2003; Zhoa et al., 2003). 
The neutral theory of molecular evolution suggests that the majority of DNA 
variations in a population are effectively neutral and the fate of neutral alleles is 
governed by genetic drift of random occurring mutations (Kimura, 1968; King & 
Jukes, 1969). In contrast, the selectionist position suggests that most new mutations 
have an effect on fitness and are affected by natural selection (Nei & Kumura, 











population through purifying/negative selection. and are thus found in reduced 
frequencies in natural populations. In contrast, natu ral select ion of advantageous 
mutations a lso occurs and th is increases the frequency and speed of fixation of a 
new allele (positive selection). Natural selection can also maintain several alleles 
over period of time (balancing selection). 
If we know which SNP al le le is derived (new mutation that has arisen in a 
populat ion) and which one is ancestral at each site we can make inferences about 
the type of selection thai has affected a set of locii using the alle le f requency 
spectrum. An alle le frequency spectrum is a count of the number of mutat ions in a 
given frequency class (Nielsen, 2005). The histogram of the numoor of derived 
alleles w ithin the different frequency classes is cal led the derived allele frequency 
s pectrum (Figure 5.1). Allele frequency spectra combine information across a large 
numoor of polymorphic loci, providing a summary of the allele frequencies of the 
various polymorphisms We expect that given a set of SNPs, an excess of rare 
derived alle les is a signature of purifying selection (Chen & Rajewsky, 2006), 
Conversely, positive selection w ill lend to increase the proport ion of high f requency 
al leles. 
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Since natural selection results in changes of allele frequency, changes in a 
population are usually described by the changes in allele frequencies. Hence, allele 
frequency has been a fundamental parameter in population genetics in the study of 
the generation and maintenance of genetic polymorphisms and to understand the 
mechanisms of evolution at the population level. Here we use allele frequency to 
study the role of natural selection in shaping the distribution of SNPs at exon-intron 
junctions of human genes. SNPs around the borders of exons and introns are more 
likely than other SNPs to have an effect on splicing; and nucleotide substitutions that 
deleteriously affect splicing are expected to be kept at low frequencies. 
5.3 Material and Methods 
5.3.1 SNP allele frequency data 
SNP allele frequencies compiled from genotype data from European, Asian and 
African populations were obtained from HapMap (http://www.hapmap.org) release 
#22. This data is also available in dbSNP. For each human SNP in the initial dbSNP 
dataset we inferred the ancestral character state of the alleles from genomic 
alignments of human polymorphism with corresponding chimpanzee nucleotide. We 
defined the 'ancestral allele' as the human allele identical to the chimpanzee allele 
and the 'derived allele' as the other human allele. Only bi-allelic, validated SNPs 
were considered for this analysis. We did not filter for monomorphic SNPs. We were 
able to define a derived allele for 8 426 200 genotyped SNPs in dbSNP. 
Using Ensembl functional annotations, the SNP data were classified according to 
their genomic positions: coding non-synonymous SNPs, coding synonymous SNPs, 
and non-coding SNPs. SNPs functional annotations also included bi-allelic SNPs 
found at the 5' and 3' splice junctions. Non-coding SNPs are located in intergenic, 












5.3.2 Derived Allele Frequency (OAF) Analysis 
Using SNP frequency information from populations of Asian, European and African 
ancestry in the HapMap database, we computed the average frequencies of the 
derived alleles as a function of distance from the exon-intron boundaries. Secondly, 
we compared the average frequency of the derived alleles of SNPs located in exon-
intron junctions with SNPs located in coding non-synonymous sites, coding 
synonymous sites and SNPs located in non-coding regions. Thirdly, we compare the 
derived allele frequency distribution of SNPs found at exon-intron junctions of CSEs 
with those found at exon-intron junctions of ASEs. Finally, we then look at the 
derived allele frequency spectra of SNPs located in the different SNP categories. 
The analysis was done using a combination of PERL scripts and the R-statistical 
package. 
5.4 Results and Discussions 
5.4.1 Derived allele frequency data 
Hap Map provides validated DNA sequence variations and allele frequencies from 
populations with ancestry from Africa, Asia, and Europe. We classified the SNPs 
into functional categories according to genomic context. Table 5.1 shows that by far 
the most common SNPs available in the dataset are non-coding SNPs followed by 
non-synonymous, synonymous and then SNPs located in the exon-intron junctions. 
Non-coding SNPs include sets of intergenic, intronic, and UTR SNPs which are 
located within the large genomic regions between the coding regions. The high 
number of non-coding SNPs in the database is a reflection of the fact that the vast 
number of SNPs in the human genome lie within the intergenic DNA sequence 











Table 5.1: Number of SNPs with derived allele frequency. 
5' splice junction 13220 13136 13667 
3' splice junction 13247 13222 13795 
Non-synonymous Coding 19345 19413 19229 
Synonymous Coding 28657 28944 28860 
Non-coding SNPs 139944 140646 137723 
Numerous studies have highlighted the possibility that SNPs outside the coding 
regions of the genes might be regulatory SNPs (rSNPs) mostly involved in gene 
expression variation (Buckland, 2004; Buckland, 2006; Montgomery et at., 2007). 
On the other hand, studies have shown that the fraction of polymorphisms at 
different functional regions of the human genome depends on the strength of 
selection on that region (Gorlov et at., 2006). Thus, a higher rate of occurrence of 
SNPs in the non-coding regions reflects the weaker or absence of selective 
pressure affecting much of the non-functional intergenic DNA. 
The higher number of synonymous relative to non-synonymous polymorphisms 
reflects the fact that the human coding sequences have more non-synonymous than 
synonymous sites. Many nucleotide substitutions in the third codon position are 
synonymous whereas the first and second codon positions have mostly non-
synonymous nucleotide substitutions. Hence, a random new mutation in a coding 












5.4.2 Derived allele frequency distribution 
Throughout the rest of this chapter we will strive to understand how natural selection 
affects SNP allele frequencies in the exon-intron junctions of human genes. We 
examine the derived allele frequency distribution of SNPs located in the entire 
±60bp exon-intron junctions (Figure 5.2a and Figure 5.2b). On average the derived 
allele frequency in the exon-intron junctions is 0.41 (SD = 0.03) in Asian, 0.40 (SD = 
0.03) in Europeans, and 0.33 (SD = 0.03) in African populations. Although the 
number of SNPs observed in the different population groups examined is similar, on 
average, Asian and European populations have similar distributions frequency of 
derived alleles, which is significantly higher (p < 2.2 x 10-16) than the frequency of 
derived alleles in the African population. We observe equal distribution of the 
average frequency of the derived alleles between the coding exonic and non-coding 
intronic positions, however, the exonic positions have significantly higher proportion 
of rare (frequency :5 0.1) derived alleles than intronic positions (p = 0.0003, Figure 
5.3a;p = 1.96x 10-7, Figure 5.3b). This is shown using data from European 
population. 
The distribution of derived allele frequency observed does not reveal the influence of 
natural selection on polymorphic sites in the exon-intron junctions. However it does 
show that derived alleles usually have lower frequency than ancestral alleles. In 
addition, we observed that the exonic regions of the splice junction are probably 
enriched with rare derived alleles compared to the intronic regions. Studies on SNP 
frequencies in human genes showed that non-degenerate regions have low 
nucleotide diversity and an excess of rare allele compared to degenerate sites 
(Sunyaev ef al., 2000). The excess of rare alleles most likely reflects the presence of 
deleterious alleles under purifying selective pressure, but could also be explained by 
the presence of recent selective sweeps (Chen & Rajewsky, 2006). 
Derived alleles arise by mutations and the effect of new mutations on gene 











coding regions, synonymous mutations do not change the amino acid sequence of 
the protein whereas non-synonymous mutations result in a different amino acid 
being placed in the sequence. Since silent changes normally affect the 
characteristics of the individual far less than would non-synonymous changes, non-
synonymous changes would be more frequently subjected to natural selection (both 
positive and negative) than would synonymous changes. Most mutations outside the 
coding regions do not affect the amino acid sequence of genes; however, those 
changes that are located within gene expression regulatory sequences are more 
likely to influence gene function. Hence we suspect new mutations in the splicing 
regulatory regions (exonic and intronic) are also subjected to natural selection. 
Harmful mutations rather than beneficial mutations are likely to occur in the splicing 
regulatory motifs found in the exon-intron junctions, and natural selection is 
expected to act against these new deleterious mutations (Nei & Kumura, 2000). 
Hence we suspect negative selection is much more common than positive selection 
in the exon-intron junctions as this is generally the case anywhere in the functional 
regions of the human genome. 
To test if negative selection operates against new mutations found in the splice sites 
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coding non-synonymous sites, coding synonymous sites, and SNPs located at non-
coding regions of the genome and the results are shown in figure 5.4. Non-
synonymous coding SNPs have the lowest average frequencies of derived alleles 
(p-values in Table 5.2a-c). This is not surprising since new non-synonymous SNPs 
disrupting the coding capacity of a gene are expected to be kept at low frequencies 
through purifying selection whereas those that are found at non-coding regions are 
expected to be under the influence of weaker or no selective pressure. 
SNPs located in the splice sites flanking the exon boundary have, on average, 
increased frequency of derived alleles compared to SNPs located in non-
synonymous and synonymous sites (Figure 5.4) but have lower average frequency 
of derived allele of SNPs in non-coding regions (p-values in table 5.2a-c). SNPs in 
non-coding regions are unlikely to be under strong selection compared to SNPs in 
the splicing regulatory regions; hence the observed average frequency of derived 
alleles of SNPs in the splice sites is understandable. Figure 5.4 suggest the low 
occurrence of SNPs near the exon boundaries is generally accompanied by higher 
frequency of the derived alleles than the coding non-synonymous and synonymous 
SNPs. Unless, positive selection serves to increase frequency of new alleles to 
improve splicing efficiency, we could not come up with a biological explanation for 
the increased frequency of the derived alleles in the splicing regulatory sites 
compared to neutral (synonymous) sites. 
The different types of exon in the human genome have been shown to exhibit 
different evolutionary pressure (Mondrek & Lee, 2003; Zheng et al., 2005; Chern et 
al., 2006; Chern et al., 2007); consequently they might display different patterns of 
derived allele frequency. We proposed that the increased frequency of derived allele 
at exonic positions near splice sites is the indication that new mutations are 
tolerated in the exon-intron junctions of some exons, especially those exons that are 
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selected againsl in ASEs. Hence, over evolutionary time new alleles might increase 
in frequency (and eventually may become fixed if tlley offer selective advantage in 
the population), allowing occurrence of SNPs Wllicll affect tile way in Ylfhich genes 
are spliced between individuals. SNPs have already been associated with 
alternative spliced patterns, allowirlg transcripl diversity amorlg humans (Kwan et 
81, 2007; Kwan el ai, 2(08). Alternatively, it is also possi~e that most SNPs in 
exon-intron junctions are evolving in an almost complete neutral manner, and tllose 
SNPs found at high frequency within a population are mostly due to genetic drift and 
few are positively selected. 
Table 5,2a: Significance (P-values) of comparisons of average frequency of derived 
alleles using European frequency data, 
Genomic "' e E~onic 5' Intronlc 3' E~onic 3' Inlronlc 3' "' Position " '" '" '" "C , < 0,05 
E~ooOc 5'SJ < 0,05 < 0.05 
Introoic 5'SJ < 0,05 < 0.05 0.5655 
Exoo Oc 3'SJ < 0,05 < 0.05 0,6367 0885 
Intronlc 3'SJ < 0.05 < 0.05 0.3647 o 7987 0 ,6508 
"' < 0.05 < 0.05 0.000184 0,0102 0.001123 0.006626 
NS " "",sY" "" yrnous, S=Sy"onyrnOLJS, SJ ~ splice iUnction. NC = Non-coding 
Table 5.2b: Significance (P-values) of comparisons of average frequency of derived 
alleles usirlg Asian frequency data. 
Genomic "' 
, bonk 5' Intronic S' Exonic 3' lntronk 3' NC 
Position OJ " " " 
'C 
C < 0,05 
xonic 5'SJ < 0.05 < 0,05 
Introoic 5'SJ < 0.05 < 0.05 0.9722 
E.""" 3'SJ < 0.05 < 0.05 0.9471 0.978 
ntrooOc 3'$..1 < 0,05 < 0.05 0.53R5 0.5345 0.4847 











N5~oon-synonymous, 5=5ynonyrnou~, 5J = ~p Oce junclioo, NC = Non-coding 
Table 5.2e: Significance (P-values) of comparisons of average frequency of derived 
alleles using African frequency data. 
Genomic ", , Exonic 5' Inlronic 5' Exonic " Intronic 3' "C Position " " " " 
"' , <: 0.05 
Exooic 5'SJ " 0.05 < 0.05 
Intronic 5'SJ " 0.05 < 0.05 0.541 
hook: 3'SJ " 0,05 " 0.05 0,7147 0,7804 
Intronic 3'SJ " 0.05 < 0.05 05% 089613 08695 
"C < 0.05 " 0.05 0.1513 0.04434 0.05015 0.02793 
N5 noo-synooyrnous. S=Synonyrnous, 5J ~ "" lice iundion, NC = Non-coding 
5.4.3 Derived allele frequency (OAF) distribution of SNPs at splice 
junctions of CSEs and ASEs 
The datascts of constitutively spliced exons (CSEs) and alternatively spliced exons 
(ASEs) allowed us to cornpare the average frequendes of derived alleles found in 
splice junctions of these two exon categories We categorize SNPs in splice 
junctions a=rding to whether they are tocated in exonic (non-synonyrnous sites, 
synonymous sites, UTR) or intronic regions and cornpute the average frequencies 
(Tablo 5,3a and Table 5,3b). We observed sirnilar distributions of tho average 
frequencies of the derived alleles in the intronic positions between these two exon 
categories; but, exonic regions show distinct characteristics of derived allele 
frequencies (OAF). P-valuos indicating the significance of the difference between 
OAF in exon-inlron junctions of CSEs and ASEs are shown in Tabte 5.4 (a, b, c), 
Generally non-synonymous sites have, on average, a lower frequency of derived 
allolos cornpared to the other regions in the splice junctions; howevor this difforonce 
is more ofton statistically significant in SNPs found in CSEs junctions than 











show decreased average frequency of derived alleles, suggesting stronger purifying 
selection, compared to synonymous SNPs located in the corresponding regions in 
CSEs. These observations are statistically significant in the 3' splice junction. 
However, the significance of the difference also depends on population data used. It 
is important to note the inconsistency in significance of the difference between the 
different population groups, highlighting differences of allele frequency between 
human populations. The differences between populations could be explained by 
mutations providing a selective advantage or disadvantage within a specific 
population but not in others. However, given that the differences are relatively small 
they are more likely to be the result of sampling (the p-values presented in the table 
are not corrected for multiple testing). 
As opposed to non-synonymous SNPs, synonymous mutations are usually thought 
to evolve neutrally in mammals. Nonetheless, when these silent mutations disrupt 
splicing regulatory sites they can cause abnormal splicing (Montera et al., 2001; 
Mankodi & Ashizawa, 2003) or activate cryptic splice sites (Deshler & Rossi, 1991; 
Denecke et al., 2004). There has been evidence suggesting selection acting on 
synonymous substitutions to ensure efficient pre-mRNA splicing (Willie & Majewski, 
2004; Gorlov et al., 2005; Chamary & Hurst, 2005a, Parmley & Hurst, 2007). A 
recent comparative genomics study characterizing the evolutionary behavior of 
splicing regulatory motifs showed strong evidence that synonymous substitutions in 
CSEs tend to create exonic splicing enhancers and disrupt exonic splicing silencers, 
implying positive selection for ESEs (Ke et al., 2008). This positive selection is said 
to be compensating for aberrant splicing and mutations that disrupt splice sites. It is 
possible that the decreased average frequency of derived alleles of synonymous 
SNPs located in the splice junctions of ASEs compared to the corresponding 
regions of CSEs is may be a consequence of positive selection acting on splicing 
promoting synonymous SNPs located in exonic splicing regulatory motifs near the 











Table 5.3a: Average freqUGrl(:y of derived al leles of SNPs located within splice 
junctions of constitutively spliced exons (CSEs). 
Popu lation CSEs 
5's;>ice juoctions 3'spltce j unc tIons 
Exonic tntronic E~onic fntronic 
" , c," " 
, C," 
Furopean 0.26 0.3~ 0.37 0.32 0.26 C~ 033 0.32 
(O,30) (0,33) (0,35) (O,32) (0.31) 1032) (0,:>0) (0.32) 
Asian 0,26 0.33 C&; 0.32 0,27 035 0.3~ 0.32 
(0,31) 10,31) (0 .35) 10,33) (0 .32) (O 32) 10.32) (0.33) 
African 0,23 0.29 0,30 0,27 0,21 0&0 0.29 0.28 
(0 .28) (0.28) (0 .30) (0 .2B) (0.27) (0 ,29) (OB) (O ,29) 
~ • NS non-synonymous, S Synonymous, UTR, un,rnn,lnted region Numbers plaero w ithin brackets 
' how "\Jr~lar6 devlat ;on 
Table 5.3b Average frequency of derived alleles of SNPs located within splice 
junctions of alternatively spliced exons (ASEs) 
POpu lO lion ASEs 
5's;>"e juoctions 3'splice juoctions 
Exonic Intronlc Exonic Intronic 
" 
, cm " , C," 
Lliropean 0.22 0 ,27 0.21i 031 0.27 0.26 0,25 0,3' 
(O,30) (0.30) (028) (O.3') (O,34) (0,28) (0 .3~) (0.32) 
Asian 0.29 0.29 033 0 .31 0.29 '"" 0,21 0,32 (03~ ) (O,32) (0,36) (O,3') (0,35) (0.31) (0 .30) (0 .33) 
Atr"an o 19 025 0.24 0.27 0,24 022 0,20 0.28 
(O,2B) (0,20) (0.24) (0,23) (0.28) (0.26) 10.25) (O.28) 
• ~ . • , NS-non·synonymouo, S Synonymous. UTR untranslated reg ion. Numoors ;.>oceL w ll!>ln br~ckets 











We further compare the OAF spectrums of SNPs located in exon-intron junctions 
with SNPs located in non-synonymous, synonymous and non-coding regions of the 
human genome (Figure S.Sa-c). We observe similar derived allele frequency spectra 
between SNPs located in exon-intron junctions of ASEs and CSEs. Compared to 
SNPs located in the splice sites, non-synonymous SNPs have an excess of low 
frequency (rare) derived alleles reflecting purifying selection acting more frequently 
on non-synonymous mutations that alter amino acid sequences (Fay & Wu, 2003; 
Chen & Rajewsky, 2006) than polymorphic sites in the splice junctions. 
The differences in derived allele frequencies between CSEs and ASEs are 
marginally statistically significant in the case of a small number of SNP categories. 
However, the differences between the derived allele frequency distributions are 
relatively small and the significant comparisons may be the result of multiple 
hypothesis testing. Statistical significance depends on the magnitude of the 
difference between the two groups compared and the sample size. The lack of 
statistical significance in these comparisons may be due to relatively small sample 
sizes of SNPs in exon-intron junctions of ASEs. However, statistics cannot be used 
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The use of population specific SNP frequency data allowed us to get a qualitative 
understanding of selection by comparing patterns of derived allele frequency 
between SNPs located at splice sites near exon boundaries with SNPs located at 
synonymous sites, non-synonymous sites and non-coding regions. Based on 
their genomic locations these different SNP categories have varying 
consequences of spliced transcript product and are subjected to different 
selective forces. As expected under selection, we observed that the frequency of 
derived alleles for non-synonymous polymorphisms is lower than the average 
frequencies of derived alleles of the other SNP categories. In addition we showed 
that SNPs in exon-intron junctions of CSEs and ASEs may be subjected to 













In this work, we directed our efforts to investigate the extent to which SNPs 
occurred in the exon-intron junctions of human genes. We identified 47 036 
SNPs in 5' and 3' exon-intron junctions (comprising 60bp of exon and 60bp of 
intron) of more than half of Ensembl annotated genes. These SNPs are more 
often located in the non-coding intronic regions than the coding exonic regions. 
The exonic regions have higher proportions of rare (frequency ::5 0.1) derived 
alleles than intronic positions, with non-synonymous coding SNPs having the 
lowest average frequencies of derived alleles. These observations reflect the fact 
that new mutations disrupting the coding sequence of a gene are kept at low 
frequencies through purifying selection whereas those that are found at non-
coding regions are expected to be under the influence of weaker or no selective 
pressure. 
In contrast to what has already been observed, the identified alternatively spliced 
exons (ASEs) have lower proportions of SNPs in their exon-intron junctions than 
constitutively spliced exons (CSEs). Nevertheless, there are specific genomic 
positions where analysis shows a higher prevalence of SNPs at spliced junctions 
of ASEs than spliced junctions of CSEs. This difference depends on genomic 
positions (exonic vs. intronic) of the SNP and also which SNP dataset is used. 
We suspect the dataset of ASE used in the study has diverse pattern of SNP 
distribution, however without categorization of ASEs into the distinct alternative 
splice patterns, comparison of the prevalence of SNPs at exon-intron junctions of 
ASEs with CSEs is not likely to produce a conclusive analysis. The different 
types of alternative splice isoforms have diverse features and this is highlighted 
by Zheng and his colleagues (2005). It might be possible that one type of splice 
pattern (i.e. cassette exon) has lower frequencies of SNPs in their exon-intron 
junctions compared to CSEs, whereas another type (i.e alternative 3' splice site) 
might have higher frequencies of SNPs than the corresponding regions in CSEs. 
Hence, further analysis of ASEs is needed for understanding of sequence 











SNPs are fewer at positions close to the exon boundaries than any other region 
in the exon-intron junctions. However, these positions are accompanied by 
increased average frequency of the derived alleles compared to non-
synonymous and even synonymous sites. The higher average frequency of 
derived alleles of SNPs in the splicing regulatory sites compared to coding 
synonymous sites is surprising, since we expected polymorphisms located within 
splicing regulatory regions to alter efficiency of splicing regulation and 
consequently to be subjected to purifying selection more often than neutral 
SNPs. Aberrant spliced transcript patterns are the underlying cause of many 
heritable human diseases; hence, we expect natural selection would act to 
reduce the frequency of new mutations altering regulatory splice sites. Unless 
natural selection frequently serves to increase the frequency of SNPs located in 
splice sites to improve splicing efficiency in CSEs, the alternative is that 
mutations that affect splicing are more strongly selected against in ASEs. The 
different types of exons in the human genome are characterized by different 
features, including different patterns of SNP distribution and derived allele 
frequency. 
A major limitation on our research methodology is the way in which we have 
identified ASEs and CSEs. We used ASAP" annotations, which only uses EST 
and cDNA sequence to identify alternatively spliced exons. EST data provide 
information on structure of ASEs and include data from different gene expression 
contexts, but this information is highly biased towards terminal exons and highly 
expressed genes. Consequently we might have missed rare alternatively spliced 
patterns and many internal ASEs; as a result these can be mistaken as CSEs. 
Furthermore, the bias towards terminal exons being identified as alternatively 
spliced may cause us to mistake characteristics of terminal exons for the 
characteristics of alternatively spliced exons. Analysis using the latest version of 
Ensembl database (Le. version 50) might greatly improved identification of ASEs 
due to availability of new information. In addition, although exon array methods 
also have their limitations, inclusion of this information for ASEs identification can 











We have identified SNPs which have already been implicated in splicing 
regulation, in our SNP dataset. These srSNPs allow production of transcript 
variants in an allele specific manner. For example, an exonic SNP (rs2295682) 
found in exon-intron junction of the RBM23 gene is associated with exon 6 
skipping. This synonymous coding SNP has a G or an A allele, and it is the A 
allele which is associated with increased exon skipping event (Hull et a/., 2007). 
Another example includes an A/G SNP at the acceptor splice site (AG/AA) of the 
OAS1 gene which causes shortening of exon 7. The A allele destroys the splice 
site and is associated with decreased enzyme activity which has been implicated 
in individuals susceptible to viral infection (Bonnevie-Nielsen et a/.,2005). This 
suggests that a fraction of SNPs at exon-intron junctions directly affect the 
pattern of alternatively spliced exons. Many more SNPs that have an effect on 
phenotypic variability, including disease susceptibility, are likely to be present in 
our database. Although we cannot estimate the extent to which all of these are 
involved in phenotypic diversity, the frequent occurrence of SNPs in critical sites 
within intron-exon junctions suggests a contribution from population variation to 
the observed diversity of splicing events. 
A significant goal of the research group in which this study was carried out is to 
establish the extent to which human alternatively spliced genes are affected by 
cis-acting splicing regulatory polymorphisms, which might either completely 
determine which isoform of the gene is produced or alter the relative proportions 
of alternative isoforms. This will enable us to determine whether the alternatively 
spliced transcript isoforms observable in the public database are the result of 
alternative splicing to increase the functional repertoire of a gene or a result of 
mutations that may be responsible for some phenotypic differences between 
individuals. As a means of contributing to this goal, we surveyed the occurrence 
of SNPs at exon-intron junctions of human genes and provided a description of 
the way in which SNPs are distributed within the exon-intron junctions, 
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